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Acceptance and Commitment Therapy (ACT) is a recently developed therapy, focusing on 
promoting psychological flexibility through mindfulness and acceptance processes and 
commitment and behaviour change (Hayes, Strosahl and Wilson, 1999). This paper provides a 
systematic review of the methodological quality of ACT intervention studies and examines the 
available evidence for ACT to alleviate psychological distress and improve quality of life for 
adults with psychological and physical health problems.
Seven papers concluded ACT was effective for reducing psychological distress and three 
papers concluded ACT was effective for improving quality of life. One paper concluded ACT 
was more effective than Cognitive Behaviour Therapy. However, all research papers were 
subject to weak methodological design, therefore studies were inadequate to provide empirical 
support for ACT. Variability in setting, duration of treatment, clinical population and 
adherence to protocol made it difficult to synthesize and compare results.
There is insufficient evidence that ACT is effective for reducing psychological distress and 
increasing quality of life in a range of clinical populations. Further research comparing ACT 
with established psychological treatment is required. Future studies should also investigate 
the effectiveness of ACT in psychological disorders where Cognitive Behaviour Therapy and 
Cognitive Therapy have had limited success. Researchers should take into account the 
limitations of previous papers when designing future intervention studies.
Keywords: Acceptance and Commitment Therapy, Systematic Review, ACT, Intervention, 
Third wave.
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Setting the scene for Acceptance and Commitment Therapy: The limitations of Cognitive 
Behaviour Therapy
The effectiveness of Cognitive Behaviour Therapy (CBT) has been supported by numerous 
controlled trials and remains the treatment of choice for Anxiety, Depression, Deliberate Self- 
Harm, Insomnia, Obsessive-Compulsive Disorder and Post-Traumatic Stress Disorder 
(Department of Health, 2000; NICE, 2004: NICE, 2005; Roth and Fonagy, 2005). Recently a 
meta-analysis of the CBT literature derived large effect sizes for Generalised Anxiety 
Disorder, Panic Disorder, Post Traumatic Stress Disorder, Social Phobia and Unipolar 
Depression (Butler, Chapman, Forman and Beck, 2006).
Whilst the efficacy and clinical utility of CBT has been demonstrated, the limitations of this 
approach are well documented (Bolsover, 2002; Holmes, 2002). Holmes (2002) claims the 
vast evidence base for CBT is due to the relative ease in which CBT can be administered and 
evaluated. This is in contrast to therapies such as Psychoanalytic Psychotherapy and Systemic 
Therapy which focus on therapeutic processes as opposed to clinical outcomes (Perron, 2006; 
Whittle, 2000). Other researchers and clinicians have highlighted the limitations of CBT 
when applied to severe and enduring psychological problems such as Borderline Personality 
Disorder (Linehan, 1993) and Bulimia Nervosa (Fairbum et al., 1993). Although leading 
cognitive therapists claim that alteration of dysfunctional thoughts are crucial for symptom 
alleviation and behavioural change (Beck et al., 1979; Beck 1995; Hackman 1997), some 
studies have identified that changes in thought do not necessarily precede changes in 
symptoms and clinical improvement during therapy can be observed prior to cognitive 
intervention (Longmore and Worrell, 2006).
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At present, CBT is the dominant psychological approach in the UK. Although clinical 
findings indicate that it can be effective for a range of disorders, definitive conclusions 
regarding the underlying processes and limitations within specific populations are still 
required.
Acceptance and Commitment Therapy
Consistent with the belief that restructuring dysfunctional thoughts may not always result in 
clinical improvement, Acceptance and Commitment Therapy focuses on changing the role of 
thoughts as opposed to altering them (Hayes, Strosahl and Wilson 1999).
ACT is one a number of ‘third wave’ behavioural treatments that has emerged in the last 10-15 
years, alongside therapies such as Dialectical Behaviour Therapy (Linehan, 1993) and 
Mindfulness-based Cognitive Therapy (Segal, William & Teasdale, 2002). Third wave 
therapies are viewed as distinctly different from ‘second wave’ therapies, whereby the 
therapist may focus on the immediate problem and seek to challenge or change cognitions. In 
‘third wave’ therapies, the therapist focuses on understanding and accepting cognitions within 
a persons’ value base and there is an emphasis on concepts such as ‘acceptance’ and ‘personal 
values’. This ethos also coincides with current recovery models for understanding and treating 
mental illness. Recovery models aim to focus on the development of a meaningful life, 
despite serious mental illness. Therefore, clinicians working within a recovery model 
framework will aim to focus away from psychiatric symptoms and steer the client towards 
developing hope and meaning in their life (Anthony, 1993).
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Acceptance and Commitment Therapy (ACT) has developed from principles of Functional 
Contextualism (Biglan and Hayes, 1996) and Relational Frame Therapy (Hayes, 2004) and is 
based on the belief that thoughts and feelings are regulated by context. Individuals should 
therefore not change thoughts themselves, but instead change the context and function of 
thoughts (Hayes, Luoma, Bond, Masuda and Lillis, 2006). Hayes et al., (1999) claims that this 
reduces the power of the dysfunctional thoughts that cause psychological distress.
(Insert Table 1 here)
The aim of ACT is to increase psychological flexibility. ACT aims to do this via six core 
principles: acceptance, cognitive defusion, being present, self as context, values and 
committed action (Table 1). Although processes interrelate, they can be grouped into 
Mindfulness and Acceptance processes (acceptance, cognitive diffusion, being present, self as 
context) and Commitment and Behaviour Change processes (values, committed action).
The evidence-base for ACT
Over the last decade, ACT interventions have been applied to a broadening range of 
psychological and physical health conditions including: Addictions (Hayes et al., 2004); 
Anxiety and Depression (Lappalainen, Lehtonen, Skarp, Ojanen and Hayes, 2007); Diabetes 
(Gregg, Callaghan, Hayes and Glenn-Lawson, 2007); Epilepsy (Lundgren, Dahl, Melin and 
Kies, 2006); Pain (Wicksell, Melin and Olsson 2007); Psychosis (Guadiano and Herbert 2006, 
Bond and Bunce 2000; Bach and Hayes 2002); Social Anxiety (Dalrymple and Herbert, 2007) 
and Trichotillomania (Woods, Wettemeck and Flessner, 2006). This has coincided with 
detailed descriptions and strategies for delivering ACT (Chantry, 2007). A number of studies 
have also examined ACT processes and results indicate that potential mechanisms of change
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are different from Cognitive Therapy (CT) and CBT (Feldner, Zvolensky, Eifert, and Spira, 
2003; Hayes et al., 2006).
Whilst the literature may convey the impression that ACT is a promising alternative to 
established psychological therapies, there is debate within the scientific community regarding 
the evidence base for this approach. Dougher (2002) questions the theoretical basis that 
language is at the core of all human suffering, as this does not explain the high percentage of 
verbally competent adults who do not suffer from a psychological disorder to some extent. 
Some clinicians and theorists also claim that ACT is simply a modernised version of CBT 
(Hofmann and Asmundson, 2008).
In a meta-analysis of ACT intervention studies (Hayes, Luoma, Bond, Masuda and Lillis,
2006) when ACT was compared with waiting list or treatment-as-usual, a relative effect size 
of 0.99 at post and 0.71 at follow-up was obtained. When compared to structured 
interventions, ACT achieved a relative effect size of 0.48 at post and 0.63 at follow-up. 
Surprisingly an effect size of 0.73 at post and 0.83 at follow-up was reported when ACT was 
compared directly to CBT or CT. However the latter analysis included only four papers, two 
of which were studies that combined ACT with another treatment. Nonetheless, Hayes et al., 
(2006) claimed that the meta-analysis supported the ACT model and although further 
intervention studies with placebo control groups were required to validate preliminary 
findings, it was suggested there was growing evidence that ACT was effective for reducing 
psychological distress and improving the quality of life in a range of psychological and 
physical health problems.
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However, the conclusions of Hayes et al., (2006) should be interpreted with caution, due to a 
number of important limitations. Firstly, the review did not examine the methodological 
robustness of ACT intervention studies. Secondly, it did not account for the variation in 
treatment protocol and delivery of ACT. This makes comparison of results more problematic 
as treatment outcomes may be directly related to non-specific aspects of treatment, such as 
duration of therapist contact and clinical setting. Thirdly, the review included participants 
from non-treatment seeking populations, such as students reporting maths anxiety (Zettle,
2003) and employment based initiatives for reducing stress at work (Bond and Bunce, 2000). 
Consequently findings from these studies cannot be generalised to clinical populations. 
Finally, and as previously discussed, Hayes et al., (2006) included studies where ACT had 
been delivered in combination with other treatments namely: behavioural techniques for 
seizure management (Lundgren, Dahl, Melin and Kies, 2006); Habit Reversal Training for 
Trichotillomania (Woods, Wettemeck and Flessner; 2006) and Dialectical Behaviour Therapy 
for women with Borderline Personality Disorder (Gratz and Gunderson, 2006). While this 
demonstrates the potential for ACT to be a flexible and additional treatment component to 
other established therapies, it limits the examination of ACT as a standalone treatment.
A recent meta-analysis of third wave behaviour therapies reported a relative effect size of 0.68 
for ACT (Ost, 2008) l. Control conditions included placebo treatment, treatment as usual, 
waitlist control and structured interventions that had been included to specifically target 
symptoms. Whilst Ost (2008) paid particular attention to the lack of scientific rigour of ACT
1 Ost (2008) was published towards the latter stages o f this present review and after the results section had been 
completed. The author included this paper in the final draft which enabled the author to compare and contrast 
findings.
7
intervention studies, the effect size was calculated using the main outcome of the study as 
identified by study authors (e.g. glycated haemoglobin results for Type 2 diabetes; drug intake 
for polysubstance abusing adults) and therefore did not look specifically at measures of 
psychological distress and quality of life. Therefore only tentative conclusions may be drawn 
regarding the effectiveness of ACT in reducing psychological distress and improving quality 
of life. In addition, Ost (2008) suffered similar limitations to that of Hayes et al., (2006) in 
terms of over inclusiveness. Ost (2008) also included non-treatment seeking populations and 
studies where ACT was combined with another intervention.
Taking into account the limitations of Hayes et al., (2006) and Ost (2008), there is a need to 
obtain a clear sense of the effectiveness of ACT to reduce psychological distress and increase 
quality of life in treatment seeking populations. This requires an evaluation of the 
methodological quality of standalone ACT intervention studies. In addition, three intervention 
studies have recently been published which were not considered in previous reviews. This 
includes an ACT intervention for Generalised Social Anxiety Disorder (Dalrymple and 
Herbert, 2007), a comparison between ACT and CBT for Anxiety and Depression 
(Lappalainen, Lehtonen, Sharp, Taubert, Ojanen and Hayes, 2007) and a comparison between 





This review aimed to assess the available evidence for the effectiveness of Acceptance and
Commitment Therapy for reducing psychological distress and improving the quality of life in
an adult treatment seeking population.
Main questions:
1. Has a protocol for delivering Acceptance and Commitment Therapy been established 
which would allow for results to be both synthesized and compared with established 
psychological therapies?
2. What are the methodological limitations of ACT intervention studies?
3. Is Acceptance and Commitment Therapy effective for reducing psychological distress in a 
range of clinical populations?
4. Is Acceptance and Commitment Therapy effective for improving quality of life in a range 
of clinical populations?
5. Is Acceptance and Commitment Therapy more effective for reducing psychological 




Search Strategy and Sensitivity Analyses
The following databases were searched electronically:
• The Cochrane Library > November (week 2) 2007.
• MEDLINE > 1980 -  November 2007.
• EMBASE > 1988 -  November (week 2) 2007.
• CINAHL > 1982 -  December (week 1) 2007.
• PsycINFO > 1985 -  December (week 1) 2007.
To ensure that the search generated an unbiased comprehensive list of both published and 
unpublished studies, the following procedure was applied: The National Research Register, 
official ACT website (http://www.contextualpsychology.org/) and World Wide Web were 
utilised to obtain details of ongoing and completed studies. For studies which were stated to 
be ongoing, researchers were contacted to see if data were available. Personal communication 
with an expert in the field (Dr Stephen Hayes, University of Nevada) was established to obtain 
details of further studies. Search sensitivity was increased by reviewing reference lists of 
included papers. In addition, a review of retrieved articles indicated that the two leading 
journals for publishing articles on Acceptance and Commitment Therapy were Behaviour 
Therapy and Cognitive and Behavioural Practice. These two journals were hand searched for 
relevant articles for the review.
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Search Term
The following key words were used in the search: ‘acceptance and commitment therapy ’ 
‘A C T’, 'acceptance ’, 'acceptance and commitment’ ‘acceptance based approaches ’ and’ third 
wave therapy ’. Keywords for selected studies were reviewed to ensure that search terms were 
satisfactory.
Article inclusion and exclusion criteria 
Inclusion:
1. Randomised controlled trials and other intervention studies where Acceptance and
Commitment Therapy was delivered as a standalone treatment package. To be 
considered, the study authors had to cite the originators of ACT and interventions 
had to be identified as ACT by the author of this review.
2. Participants were required to be actively seeking treatment for psychological or 
physical health problems.
3. Study reports a minimum of ten participants.
4. Unpublished randomised trials.
Exclusion:
1. Single case studies.
2. Unpublished thesis’s which were not randomized controlled trials.
3. Studies with less than ten participants.
4. Interventions that employed only aspects of ACT or combined ACT with another 
intervention.
5. Participants were under 18 years of age.
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Reliability about decisions of inclusion
Two independent reviewers assessed inclusion of studies (masked). Disagreements about 
particular papers were resolved by consensus agreement.
Quality Assessment
Study quality was assessed using an idiosyncratic tool developed by the researcher (appendix 
1.2). This was based on a scale for measuring treatment quality (Yates, Morley, Eccleston and 
Williams, 2005) and an instrument for assessing the methodological robustness of clinical 
trials (Cho and Bero, 1994). In addition, the author included items that assessed the reliability 
and validity of measures of psychological distress and quality of life
The quality assessment tool was subdivided into four scales assessing the following: treatment 
/ adherence to protocol (6 items), methodology (22 items), assessment of psychological 
distress (3 items), and assessment of life quality (2 items). The tool was comprised of a total 
of thirty-three items giving a maximum score of sixty-one. The total score was the sum of the 
treatment /  adherence to protocol subscore and methodology subscore. This was divided by 
the potential score that could be obtained for a particular study and is reported as a percentage. 
This format was developed to allow studies to be compared in a standard way and contribute 
to the research questions posed. In addition, the structure reduced the potential for studies 
scoring low or high on a particular scale to be misinterpreted. As the tool was developed for 
the purpose of this study, CONSORT guidelines for reporting clinical trials were also used to 
as a guide for assessing randomised controlled trials (Begg, Cho, Eastwood, Horton, Moher, 
Olkin Pitkin, et al., 1996).
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Studies that scored eighty percent or above were deemed to be of high quality, those that 
scored between fifty and seventy-nine percent were considered to be of moderate quality and 
those that scored forty-nine percent or below were classified as poor quality. Quality was 
assessed by the author and an independent rater.
Results:
Description of studies
The search terms above retrieved a total of sixty-seven papers. Of these, sixty were excluded 
based on abstract alone. A further paper was added following a review of ACT intervention 
studies publicised at http://www.contextualpsychology.org/. This resulted in a total of eight 
papers with a sample size of five-hundred and seventeen participants. The results of the 
search strategy are illustrated in appendix 1.3 and reasons for exclusion of studies are 
presented in appendix 1.4. Eleven studies were excluded as participants were from non­
treatment seeking populations, eleven studies were excluded as they had a sample size of less 
than ten and seven studies were excluded as ACT was used in conjunction with another 
treatment. Nine papers included in Ost (2008) did not meet inclusion criteria and a further 
four papers were added. This consisted of three recently published papers and one 
unpublished thesis. The ratio of included to excluded studies was 1:6.
Study quality ratings ranged from fifty-seven percent to eighty-six percent with a mean of 
seventy percent. Only one study was considered high quality (Gregg et al., 2007) and seven 
studies were deemed to be of moderate quality. Agreement between raters were consistent.
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A summary of the main findings for each study can be viewed in Table 2. Seven studies were 
described as randomised controlled trials. Four studies compared ACT with a treatment 
method which previous research had shown to be effective within that particular population. 
These were comprised of a comparison of individual sessions of ACT with individual 
sessions of CBT for patients reporting anxiety and depression (Lappalainen et al., 2007); a 
group intervention comparing ACT with Panic Control Treatment (PCT) for panic disorder 
(Karekla, 2004); a comparison of individual sessions of ACT with individual sessions of CT 
for patients reporting anxiety and depression (Forman et al., 2007); and a combination of 
group and individual treatment sessions of ACT compared with an intensive twelve-step 
facilitation programme for polysubstance abusing methadone-maintained opiate addicts 
(Hayes et al., 2004). ACT was compared with treatment-as-usual in three papers. Studies 
included a one-day group workshop for patients with Type 2 diabetes (Gregg et al., 2007) and 
two trials involving individual and group treatment sessions, which compared ACT with 
treatment-as-usual for patients with psychosis (Bach and Hayes, 2002; Guadiano and Herbert,
2006). One study was a time series trial examining individual sessions of ACT for 
Generalised Social Anxiety Disorder (Dalrymple and Herbert, 2007).
Has a protocol for delivering Acceptance and Commitment Therapy been established which 
would allow for results to be synthesized and compared with established psychological 
therapies?
The first part of the review process examined if a clear account of treatment was provided (e.g. 
setting, duration, and length of sessions) and if investigators took appropriate steps to ensure 
treatment was delivered as intended by trained and competent therapists. Consideration was
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then given to see if a protocol for delivering ACT had been established which allowed for 
results to be synthesized and judged in relation to treatment outcome.
The quality of treatment descriptions and adherence to protocol ranged from twenty-five 
percent to eighty-three percent with a mean of sixty-eight percent. An example of poor quality 
can be seen in Forman et al., (2007). This study randomised participants with anxiety and 
depression to either ACT or CT. Assessors were aware of treatment condition and reporting 
of protocol and treatment duration was vague. Furthermore, it was difficult to ascertain actual 
treatment interventions used by therapists as use of a treatment manual was rejected in favour 
of delivering therapy in a naturalistic setting.
The mean treatment duration for ACT intervention studies was twelve hours, ranging from a 
three hour workshop for adults with Type 2 Diabetes (Gregg et al., 2007) to fifty-six hours of 
thirty-two weekly individual sessions, plus sixteen group sessions for polysubstance abusing 
adults (Hayes et al., 2004). Delivery of treatment was either in the form of individual sessions 
(Lappalainen et al., 2007; Gaudiano and Herbert, 2006; Bach and Hayes, 2002; Dalrymple and 
Herbert, 2007 and Forman et al., 2007) group sessions (Gregg et al., 2007 and Karekla, 2004) 
or a combination of both (Hayes et al., 2004). All treatment was carried out in outpatient 
settings apart from studies which were conducted in wards for patients with psychosis 
(Gaudiano and Herbert, 2006; Bach and Hayes, 2002). Whilst seven studies reported use of a 
treatment manual, four of the investigators failed to introduce adherence measures 
(Lappalainen et al., 2007; Bach and Hayes, 2002; Karekla, 2004 and Forman et al., 2007).
15
Only one study (Gregg et al., 2007) used a measure for examining if participants had been 
actively engaging with treatment (e.g. homework).
Therapist information (e.g. experience and number of therapists) was provided in seven 
papers. Clinical outcome may have been due to therapist effects in Gregg et al., (2007); 
Guadiano and Herbert, (2006); and Bach and Hayes (2002) as only one therapist was used in 
each study. Therapist effects could not be accurately examined in Lappalainen et al., (2007) 
and Forman et al., (2007) as fourteen therapists and twenty-three therapists were used in each 
condition respectively. Therapists mainly consisted of doctoral / master level students.
In conclusion, a protocol for delivering ACT has not been established. Whilst a clear account 
of treatment was provided in seven papers which would allow future studies to be replicated 
within similar populations, there was vast variation in terms of setting, duration of treatment, 
clinical populations and adherence to protocol. Consistency of ACT is necessary at a 
conceptual and practical level to evaluate therapy. The characteristics of treatment appear to 
be the result of resources available to the researchers conducting the study, as opposed to 
following a treatment protocol based on previous research. The relation between treatment 
quality and clinical outcome will be discussed in a subsequent section.
What are the methodological limitations of ACT intervention studies?
The quality of methodological design ranged from fifty-nine percent to eighty-seven percent 
with a mean of seventy-two percent. Only one paper was deemed as being of high quality 
(Gregg et al., 2007). This study justified the size of sample based on previous literature, 
randomisation and blinding procedures were robust, intention-to-treat analyses were
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performed and attrition rates were discussed. However, despite this paper being considered 
high quality, ACT was not compared to a placebo control, follow-up was less than six months 
and as discussed, the intervention was carried out by one therapist, threatening internal 
validity.
All other papers were classified as being of moderate quality. In the four studies where ACT 
was compared with an established psychological treatment (Lappalainen et al., 2007; Karekla, 
2004; Forman et al., 2007; Hayes et al., 2004) randomisation procedures and blinding 
procedures were considered to be of poor quality, in relation to quality standards described by 
Cho and Bero (1994) and CONSORT guidelines for reporting clinical trials (Begg et al., 
1996). When ACT was compared with treatment-as-usual for patients with psychosis, 
participants in the experimental group received more time in therapy (Guadiano and Herbert, 
2006; Bach and Hayes, 2002). Outcomes may therefore be directly related to the duration of 
therapist contact.
There was a degree of variation in terms of the reporting of statistical analyses. All papers 
except Gregg at al., (2007) were either underpowered to detect significant differences at 
follow-up, or investigators failed to provide any justification for sample size. Analyses 
reported in Bach and Hayes (2002) and Hayes et al., (2004) were difficult to interpret and 
studies generally failed to report exact p values. Confidence intervals or statistical results 
were partially reported in four studies (Lappalainen et al., 2007, Karekla 2004; Forman et al., 
2007; Hayes et al., 2004). Intent-to-treat analyses were performed in five papers (Gregg et al,
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2007; Guadiano & Herbert, 2006; Dalrymple & Herbert, 2007; Forman et al, 2007; and Hayes 
et al, 2004).
A period of six months or more was considered to be an adequate measure of sustainable 
change for examining lasting effects of treatment. Follow-up data meeting this criterion were 
only available in two papers (Lappalainen et al., 2007 and Hayes et al., 2004). Re­
hospitalisation rates for patients with psychosis were evaluated at four months (Guadiano and 
Herbert 2006; Bach and Hayes). This length of time may be considered rather brief given the 
high risk of relapse and variation in remission time for psychosis (Bebbington, Tom, Garety, 
Fowler, Dunn, Colbert, Fomells-Ambrojo, Kuipers; 2006). A follow-up period of only three 
months was identified in two papers (Gregg et al., and Dalrymple and Herbert 2007) whilst 
one paper completed assessment at post treatment only (Forman et al., 2007). Information on 
attrition rates were available for all studies. Lappalainen et al., (2007) reported one-hundred 
percent retention of participants, whilst the other papers reported drop out rates of between 
fifty-one percent and eighty-eight percent (Gregg et al., 2007; Hayes et al., 2004; Forman et 
al., 2007; Karekla, 2004; Bach and Hayes, 2002; Dalrymple and Herbert, 2007 and Guadiano 
and Herbert, 2006).
In conclusion, only one paper was deemed to be of high quality and still had notable 
limitations. All other studies were considered to be of moderate quality and are therefore 
inadequate in answering the questions posed by this review. Lack of information regarding 
the psychometric properties of measures, small sample sizes and insufficient follow-up data 
weakens findings reported in previous reviews.
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Is Acceptance and Commitment Therapy effective for reducing psychological distress in a
range of clinical populations?
Although this review set out to clarify the effectiveness of ACT for reducing psychological 
distress, as previously stated, this question could not be answered due the quality of 
intervention studies reported in the literature. Findings in this section should therefore be 
interpreted with caution.
Seven of the studies used a valid and reliable measure of psychological distress. This consisted 
of self-report data (Lappalainen et al., 2007; Guadiano and Herbert, 2006; Dalrymple and 
Herbert, 2007; Karekla, 2004; Forman et al., 2007 and Hayes et al., 2004) clinician data 
(Guadiano and Herbert, 2006 and Dalrymple and Herbert, 2007) and re-hospitalisation data 
(Gaudiano and Herbert, 2006; Bach and Hayes, 2002). The quality of psychological 
assessment was based on researchers providing sufficient justification and information about 
the psychometric properties of measures that were used and reporting sufficient follow up. 
Scores ranged from zero to one-hundred percent with a mean of eighty percent.
When possible, effect sizes using Cohen’s categories of effect size (Cohen, 1992) were 
calculated by the author. Uncorrected effect sizes are reported in this section (relative effect 
sizes are reported in Table 2 and will be discussed in a subsequent section).
For participants reporting anxiety and depressive symptoms, a large effect size was obtained 
on the Symptom Checklist 90 (Lappalainen et al., 2007), a large and moderate effect size was
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obtained on the Beck Depression Inventory (Lappalainen et al., 2007; Karekla, 2004) and a 
small effect size was obtained on the Beck Anxiety Inventory (Forman et al., 2007). At four- 
month follow-up, patients receiving an ACT intervention for psychosis, generated large effect 
sizes on the Brief Psychiatric Rating Scale and Clinical Global Impressions - Severity Scale. 
Re-hospitalisation rates were reduced by fifty percent for patients admitted to an inpatient unit 
for psychosis (Guadiano and Herbert, 2006; Bach and Hayes, 2002). A large effect size was 
obtained for patients meeting criteria for panic disorder as indicated by scores on the Beck 
Depression Inventory and The State and Trait Anxiety Inventory Form -  Trait (Karekla,
2004). ACT produced a moderate effect size on the Anxiety Control Questionnaire - reaction 
subscale for patients with Generalised Social Anxiety Disorder (Dalrymple and Herbert,
2007). A small effect size was observed on the Beck Depression Inventory and Symptom 
Checklist-90 Revised following an ACT intervention for patients being treated for 
polysubstance misuse (Hayes et al., 2004).
Thus, although ACT interventions may not always target psychological symptoms 
specifically, they may reduce distress in a range of populations. However this can only be 
confirmed following controlled treatment trials of high quality. It is interesting to note that 
duration and quality of treatment were not directly related to improvements in psychological 
distress. A study consisting of fifty-six hours of ACT only achieved a small effect size 
(Hayes et al., 2004) in contrast to a large effect size following a three-hour ACT intervention 
(Guadiano and Herbert, 2006). However, this outcome was achieved in an acute inpatient 
ward where there may have been potential confounding variables with regards to other life 
changes that are associated with a hospital admission. This finding reinforces the need to
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establish a protocol for delivering ACT as factors such as setting, clinical population, therapist 
effects and outcome measures may influence results.
Is Acceptance and Commitment Therapy effective in improving quality of life in a range of 
clinical populations?
Quality of life was assessed in three studies (Dalrymple and Herbert, 2007; Karekla, 2004; 
Forman et al., 2007). All data were obtained from self-report measures. Similar to 
psychological distress, quality of assessment was determined, by authors of the studies 
providing justification for choosing particular measures. Measures which assessed only one 
dimension (e.g. sexual functioning) were insufficient. Effect sizes were calculated by the 
author of this review when sufficient information was provided.
Quality ranged from fifty to one-hundred percent with a mean of seventy-two percent. 
Dalrymple and Herbert (2007) investigated the effect of twelve hours of ACT in a sample of 
patients with Generalised Social Anxiety Disorder. They reported a medium effect size post 
therapy and a large effect size at follow-up on the Quality of Life Inventory. However, this 
study did not have a control group and effects may have been due to non-specific aspects of 
treatment. Information required for calculating effect sizes for participants with Panic Disorder 
as defined by the Short-form Health Survey was not provided (Karekla, 2004) although the 
authors of the study reported a significant increase in quality of life over time. Finally a trivial 
effect size following 15.6 hours of ACT was gained for participants suffering from anxiety 
and depression (Forman et al., 2007). This was indicated by scores obtained from the Quality 
of Life Index and Satisfaction with Life Scale.
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In conclusion, only three papers provided information on the quality of life of participants 
following an ACT intervention. Although all studies reported positive outcomes, clinical 
improvement varied. As studies were of moderate quality, conclusions regarding the 
effectiveness of ACT for improving quality of life cannot be drawn at this time.
Is Acceptance and Commitment Therapy more effective for reducing psychological distress 
and increasing quality of life when compared with established therapies in controlled trials? 
ACT was compared to another psychological therapy in four studies (Lappalainen et al., 2007; 
Karekla, 2004; Forman et al., 2007 and Hayes et al., 2004). In terms of primary outcome 
measures as defined by study authors, one study obtained a moderate effect for ACT when 
compared with CBT (Lappalainen et al., 2007). However this only included a four month 
follow-up and therapists were limited in their use of CBT interventions. In addition, the 
randomisation process was vague and investigators were not blind to treatment. A further 
three studies did not report significant differences between groups in terms of primary 
outcome measures for panic disorder (Karekla, 2004), anxiety and depression (Forman et al.,
2007), and patients reporting polysubstance abuse (Hayes et al., 2004).
In terms of psychological distress, Lappalainen et al., (2007) reported a small to medium 
effect between ACT and CBT in favour of ACT. This was obtained using the Symptom 
Checklist 90 and the Beck Depression Inventory. However, as discussed this paper may have 
been vulnerable to ACT bias. There was no difference between groups reported in Karekla 
(2004); Forman et al., (2007), and Hayes et al., (2004).
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In relation to quality of life measures, Dalrymple and Herbert (2007) did not compare ACT to 
a control group. Forman et al., (2007) reported that CT obtained a small effect size on the 
Quality of Life Index and Satisfaction with Life Scale, whilst effect sizes reported in the ACT 
group were trivial. There was no difference between groups reported in Karekla (2004).
Consequently papers included in this review provide no preliminary evidence that ACT is 
more effective that CBT or CT. These results cast further doubt over findings reported in 
Hayes et al., (2006) and Ost (2008).
Discussion
A systematic review of eight studies was conducted to examine if a treatment protocol for 
delivering ACT had been established. In addition, this review also examined if evidence was 
available to evaluate the effectiveness of ACT to reduce psychological distress and improve 
quality of life in treatment seeking populations. Despite the increasing number of ACT 
intervention studies being applied in a range of settings, only eight studies met criteria for this 
review. It is also of interest that the majority of papers were published in low impact journals 
(Social Science Citation Index; Thomson.com, 2008). Considering that inclusion criteria were 
established to ensure all standalone intervention studies utilising a clinical population would 
be included, this number is surprising. The majority of intervention studies could not be 
included in this review as they used participants from non-treatment seeking populations, had 
sample sizes of less than ten, or combined ACT with another treatment.
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The papers which did meet inclusion criteria were of poor quality as indicated by available 
guidance for assessing treatment interventions (Cho and Bero, 2004; Begg et al., 1996). The 
methodological problems highlighted by this review are similar to those identified by Ost 
(2008). It is therefore imperative that future intervention studies address such limitations. This 
can be achieved by the following: increasing the number of rigorous randomised controlled 
trials utilising placebo control groups, recruiting larger sample sizes to increase that power of 
the studies and account for high attrition levels, ensuring that intention-to-treat analysis are 
performed and that there are adequate follow up periods of at least one year. In addition, an 
evidence base can only be obtained once results are replicated within particular settings and 
populations. This would require an established ACT protocol for evaluating treatment. This 
can be established via satisfactory reporting of treatment content, using treatment manuals and 
having standardised tests for measuring therapist adherence, client engagement and clinical 
outcome.
Due to the quality of ACT intervention studies, the questions posed at the beginning of this 
review could not be answered. There is some potential support that ACT can reduce 
psychological distress and improve quality of life, however as yet there is no indication that it 
would be superior to established psychological treatment such as CBT.
In light of this, consideration should be given to the clinical and economic cost of continuing 
with a research paradigm that compares ACT with CBT and or CT, in clinical populations 
where an evidence base has already been established. Whilst Ost (2008) suggests that future 
intervention studies should compare ACT with CBT in common psychiatric disorders, there is
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some doubt about what this would achieve, as the current literature indicates that clinical 
outcomes are often the same.
As clinical improvement may be achieved via different mechanisms in ACT (e.g. acceptance 
processes and experiential avoidance as opposed to cognitive restructuring) perhaps a 
worthwhile endeavour would be the application of ACT in areas such as Personality Disorders 
and Eating Disorders. CBT has been shown to be less effective in such populations and 
acceptance may be a more realistic clinical outcome. Findings from research examining 
Dialectical Behaviour Therapy, a therapy sharing similar characteristics with ACT would 
suggest that ACT interventions may be effective (Linehan, Comtois, Murray, Brown, and 
Gallop, 2006). A future area of research should therefore be whether reduction of 
psychological distress can be obtained via ACT processes such as acceptance. Future studies 
should therefore compare CBT to ACT in a randomised controlled trial. Given the severe and 
enduring nature of these disorders, therapists would be required to be experienced clinicians 
and highly skilled in delivering CBT and ACT.
Ost (2008) concluded his review by considering how long a therapy can remain young and 
promising? It appears that now is a critical time for ACT and careful thought regarding the 
application and potential outcomes of this therapy in controlled trials is required. As 
suggested by Ost, future research may focus on increasing the number of rigorous clinical 
trials that compare ACT with CBT or CT. This may identify that ACT can obtain better 
clinical outcomes. Alternatively, could focus on comparing ACT with CBT in clinical
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populations where CBT interventions have had least success. The latter would involve 
identification of particular clinical populations and robust controlled trials.
Limitations of present review
There are some weaknesses that limit the findings of this review. Firstly the Quality Rating 
Scale was developed by the author using aspects of quality scales developed by Yates et al., 
(2005); and Cho and Bero (1994). Therefore questions may be raised in relation to the 
reliability and quality of this scale as a study which was classified as being of high quality had 
notable weaknesses. Secondly, this review had strict inclusion criteria which may have 
resulted in the exclusion of high quality studies and therefore provided an unfair reflection of 
the ACT literature. Nevertheless, the inclusion criteria adopted allowed for an accurate review 
of the application of ACT as a standalone intervention in treatment seeking populations.
Conclusion
There is no compelling evidence that ACT is a clinically effective treatment. The published 
literature is of poor quality when compared against gold standard trials criteria. Comparisons 
with suitable control conditions are required to test against placebo effects, and with 
established CBT interventions to consider the potential role of ACT in patient care. 
Overarching needs are for ACT to be more standardised and distinct from CBT, and for 
outcome measures to be defined and compared. It may be, for example, that acceptance per se 
is the valid achievable outcome in relation to certain disorders, whereas symptom relief and 
/or symptom remission may be appropriate to other disorders. There is a need therefore, to be
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able to compare evidence within patient populations on the relative efficacy of ACT and CBT 
and on such specific outcomes.
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• Therapist actively encourages client to experiment with stopping the 
struggle for emotional control and suggests willingness as an 
alternative.
• Therapist helps client investigate the relationship between levels o f  
willingness and suffering (willingness suffering diary; clean and dirty 
suffering).






• Therapist helps client experience the qualities o f willingness (a choice, a 
behaviour, not wanting, same act regardless o f how big the stakes).
•  Therapist uses language conventions, metaphors and experiential 
exercises to create a separation between the client’s direct experience 
and his/her conceptualization o f that experience.
• Therapist uses various exercises, metaphors and behavioural tasks to 
reveal the conditioned and literal properties o f language and thought 
(e.g., milk, milk, milk; what are the numbers?).
Being Present Getting in contact with 
the Present Moment
• Therapist detects “mindiness” (fusion) in session and teaches the client 






• Therapist helps the client differentiate self-evaluations from the self that 
evaluates (thank your mind for that thought, calling a thought a thought, 
naming the event, pick an identity).
• The therapist employs behavioural tasks (take your mind for a walk) to 
help client practice distinguishing private events from the context o f self 
awareness.
Values Defining Valued 
Directions
• Therapist helps clients clarify valued life directions.
• Therapist helps client “go on record” as standing for valued life ends.
• Therapist teaches clients to distinguish between values and goals.
Committed
Action
Building Patterns o f  
Committed Action
• Therapist helps client value based goals and build a concrete action 
plan.
• Regardless o f the size o f action, therapist helps client appreciate the 
special qualities o f  committed action (e.g., increases in sense o f vitality, 
sense o f moving forward rather than backward, growing rather than 
shrinking).
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Does ‘acceptance’ have a role to play in managing Idiopathic Insomnia?
A group comparison of beliefs, coping style and treatment acceptance in Idiopathic 
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Primary Insomnia is a complex and heterogeneous disorder. The International Classification 
of Sleep Disorders (ICSD-2) recognises the heterogeneity of this condition and distinguishes 
between psychophysiological insomnia (PI), idiopathic insomnia (II) and paradoxical 
insomnia. Regardless of subtype, patients with insomnia are currently managed in the same 
way. This study aimed to examine potential differences in the way adults with PI and adults 
with II conceptualise their sleep difficulties, and to consider the wider implications for the 
clinical management of insomnia subtypes. It was hypothesised that adults with II would 
perceive their insomnia to be more permanent and uncontrollable than adults with PI. It was 
hypothesised that higher levels of insomnia acceptance would be present in adults with II. It 
was also expected that adults with II would be more accepting of an acceptance-based 
approach to managing their insomnia.
The present study was a cross sectional between-groups design. Participants were volunteers 
who responded to an e-mail / poster campaign for normal sleepers (n = 31), PI (n = 31) and II 
(n = 30). The primary dependent variables were: the timeline perceptions domain of the Illness 
Perception Questionnaire-Revised; the acceptance subscale of the Illness Cognition 
Questionnaire; the personal control subscale and treatment control subscale of the Illness 
Perception Questionnaire-Revised; the Brief COPE; and the Treatment Acceptability Scale. 
Data were examined using one-way ANOVA, Chi-squared tests, Independent and Related 
Samples t tests and Correlation analyses.
Adults with II perceived their insomnia to have more permanency than adults with PI. Whilst 
both groups rated behavioural therapy as more acceptable than a pharmacological or 
acceptance-based approach, adults with II rated an acceptance-based approach as more 
acceptable than adults with PI. Methodological limitations and possibilities for future research 
are discussed.




Primary insomnia is a repeated failure to initiate, maintain or achieve high quality sleep that 
does not occur exclusively in the context of another medical, psychiatric, or substance abuse 
disorder [Diagnostic Statistic Manual for Mental Disorders, Fourth Edition (DSM IV), 1994; 
International Classification of Sleep Disorders, Second Edition (ICSD-2), 2005]. 
Epidemiological studies report prevalence rates ranging from six to thirty-eight percent, 
depending on methodological robustness and definition of insomnia utilised (Ohayon, 2002). 
The National Institute of Clinical Excellence (NICE) recently reported that an estimated £22.3 
million was spent annually on pharmacological interventions for insomnia in the UK (NICE, 
2004). The high prevalence rate and associated cost for managing the disorder, have resulted 
in a marked increase in scientific and clinical research into insomnia. This has led to 
recognition that psychological factors are critical to the development, maintenance and 
management of insomnia (Espie et al., 2001; Wang et al, 2005; Summers et al., 2006).
Although people experiencing insomnia can report similar symptoms in relation to sleep 
disturbance and daytime functioning, insomnia is a complex and heterogeneous condition. 
Research has shown that presentations of insomnia may vary in terms of the following aspects: 
severity (Morin and Espie, 2003); developmental pathways (Espie, 2002), age o f onset (Hauri 
and Olmstead, 1980; Hauri, 1983; Philip and Guilleminault, 1996; Edinger et al., 1988) and 
duration (Sateia et al., 2000). Although clinical trials have demonstrated that Cognitive 
Behaviour Therapy can be effective for insomnia (Irwin et al., 2006) nineteen to twenty-six 
percent of adults fail to show clinical improvement (Harvey and Tang 2003). The 
heterogeneity of this population, may account for some of the variation in response to
48
psychological treatment. However, further research examining the relationship between 
treatment response and variation within insomnia subtypes is required.
Insomnia subtypes
During the course of a lifetime, most individuals will experience sleep disturbance due to 
periods of acute stress. This type of insomnia is referred to as Adjustment Insomnia, whereby 
the sleep disturbance is correlated with a clearly identifiable stress or change in the 
environment. This type of insomnia is distinctly different from Primary Insomnia, which does 
not occur in the context of such psychological or environmental factors. The two main 
classification systems for sleep disorders differ in terms of the extent to which they 
acknowledge the heterogeneity of adults experiencing primary insomnia (Table 1). DSM-IV 
adopts a ‘lumping’ approach to insomnia, where primary insomnia would include all persons 
reporting difficulties associated with initiating or maintaining sleep for at least one month. In 
contrast, ICSD-2 does not use the term primary insomnia, but recognises the clinical value of 
identifying insomnia subtypes and adopts a ‘splitting’ approach. This distinguishes between 
Psychophysiological Insomnia (PI), Idiopathic Insomnia (II) and Paradoxical Insomnia. The 
terms primary insomnia and PI are often used interchangeably to describe patients in the sleep 
literature.
(Insert Table 1 here)
A number of researchers have investigated the clinical utility of ICSD-2 subtypes in 
understanding the aetiology of insomnia and for developing effective treatment interventions
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(Hauri and Olmstead, 1980; Hauri, 1983; Philip and Guilleminault, 1996; Edinger et al., 1988; 
Edinger and Krystal, 2003; Buysse et al., 1994). A literature review by the DSM-IV Work 
Group on Sleep Disorders, concluded that the term Paradoxical Insomnia (previously Sleep 
State Misperception) was a prevalent feature of chronic insomnia, rather than a distinct 
subtype. In addition, the group concluded that although the terms PI and II offered clinical 
value, there was limited empirical support to propose such a distinction. Thus, the group 
recommended that the term primary insomnia should remain in DSM IV (Reynolds et al., 
1991).
Whilst PI and II share common features, there are a number of differences which may have 
implications for the clinical management of insomnia. According to ICSD-2 criteria, whilst 
adults with PI can often identify a psychological or medical trigger, adults with II are unable 
to identify a precipitant to their sleep difficulties. In addition, PI is considered to be a learned 
or conditioned response typically developing in adulthood. Whereas II is defined as a life-long 
inability to obtain adequate sleep with onset during infancy or childhood. This suggests that II 
may be more likely to have a physiological basis (Table 2). At present, researchers often fail 
to distinguish between PI and II, and most research is carried out on patients meeting DSM 
criteria for primary insomnia or ICSD-2 criteria for PI. For this reason, present knowledge 
about the variability between both subtypes, in relation to psychological and pharmacological 
interventions for insomnia is limited.
(Insert Table 2 here)
50
Pyschophysiological Insomnia and Idiopathic Insomnia
The concept of II (also referred to as childhood-onset insomnia) was originally developed 
from the notion that a system as complex as the one that induces and maintains sleep, would 
fail to function consistently at an optimal level in humans. As previously indicated, few 
studies have been conducted within this population. Hauri and Olmstead (1980) reviewed case 
notes containing polysmnography (PSG) recordings and psychological measures for thirty- 
nine patients with PI and twenty patients with II and found significant differences in 
recordings. The II group demonstrated abnormally low phasic Rapid Eye Movement (REM), 
had a longer period of sleep onset and experienced shorter sleep duration. The PI group 
experienced more restlessness in their sleep. A prevalence of minimal brain dysfunction in the 
II group was also reported. In addition, those in the PI group were found to be more likely to 
identify a psychological precipitant for insomnia, in contrast to those with II. This study 
indicated that individuals with II slept differently from individuals with PI. The authors 
suggested that sleep related difficulties in II were more likely to be physiological than 
psychological.
In light of such findings, Hauri (1983) conducted a cluster analysis of eighty-nine patients 
with insomnia and ten good sleepers. Clusters were generated using PSG recordings, clinical 
interviews and scores obtained from the Multiphasic Personality Inventory (MMPI). Results 
provided empirical as opposed to clinical evidence to support insomnia sub-classification.
Nine distinct clusters were generated, ranging from good sleepers, to insomnia associated with 
personality factors and insomnia associated with lifestyle factors. In particular, two clusters 
were specific to individuals reporting a childhood onset. The analysis distinguished between
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moderate childhood-onset {cluster 7) and severe childhood-onset {cluster 8). Both groups 
displayed poor sleep recordings and evidence of minimal brain dysfunction, however PSG 
showed that the severe group had poorer sleep efficiency and a lack of delta sleep. This group 
was also more likely to use denial and repression as a psychological defense when coping with 
stress. Hauri suggested that this was perhaps due to the severity of insomnia in childhood and 
that individuals had learned to cope with difficulties via a pattern of denial and repression.
The moderate group displayed normal psychological profiles according to scores obtained 
from the MMPI..
Whilst this study implied that individuals with severe II may have a distinct psychological 
profile, the study was statistically underpowered, with only eight participants in cluster 7 and 
four participants in cluster 8.
Edinger et al. (1988) provided further evidence of psychological differences within insomnia 
subtypes. This study was also one of the first to examine variation in response to treatment. A 
cluster analysis was performed on seventy adults with insomnia using MMPI scores, 
information obtained from a clinical interview, and clinical response to behavioural treatment 
for insomnia. Behavioural treatment was five group sessions consisting of sleep education, 
stimulus control and relaxation. This analysis generated two subtypes: Type 1 patients were 
more likely to have reported insomnia in childhood. Individuals in this cluster described 
fewer psychological difficulties and had a weaker physiological sleep system. They also 
displayed higher levels of arousabilty and reported more sleep disruptive cognitions. Type 2 
patients scored higher in terms of neuroticism scores on the MMPI. Whilst improved clinical
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improvement following treatment was observed in Type 2, Type 1 patients were generally 
unresponsive.
In accounting for differences in treatment response, the authors claimed that insomnia for 
individuals in Type 1 were more likely to be due to physiological abnormalities and that such 
individuals were biologically predisposed to poor sleep. This would suggest that an approach 
taking into account both biological and intrapsychic factors should merit further investigation.
However, Philip and Guilleminault (1996) failed to replicate findings reported in previous 
studies. The authors investigated sixty-five adults with insomnia and fifty adults with 
Obstructive Sleep Apnoea Syndrome, analysing PSG recordings and data obtained from a 
clinical interview. The insomnia group were further subdivided based on whether insomnia 
had developed in childhood (n = 27) or adulthood (n = 38). Although there were subtle 
differences in relation to higher subjective reports of nightmares, fear of the dark and longer 
sleep latencies in the II group, no significant differences were identified in terms of PSG 
recordings and psychological measures. This study did not look at response to treatment.
Despite inconsistencies reported in the literature, three of the four studies examining 
differences between PI and II reported physiological differences, thus indicating that 
abnormalities in the neurological systems may be affecting the sleep-wake cycle. 
Neurophysiological studies have identified that anterior parts of the hypothalamus are 
associated with sleep and posterior parts of hypothalamus are associated with wakefulness, 
and individuals display either hyperactivity or hypoactivity in these areas (Sano, 1998).
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A review of the literature on insomnia and hyperarousal (Bonnet and Arand, 1997) concluded 
that sleep onset and sleep duration are determined by not only how long an individual has been 
awake, but by their natural level of arousal which determines sleep requirement. Bonnet and 
Arand stated that sleep and arousal systems are generally stable over time and that lifelong 
sleeplessness is attributed to the neurological control of the sleep-wake cycle. Whilst 
hyperarousal can be present in all individuals experiencing insomnia (Nofzinger et al.,
2004), it appears to be highly prevalent in II (Edinger et al., 1988).
In conclusion, there is a paucity of research exploring differences between PI and II. A 
general limitation of all previous studies was failure to define participants according to robust 
diagnostic criteria. In addition, investigators did not perform a priori or post hoc power 
calculations to determine the size of sample required for detecting significant differences 
between groups.
Nevertheless, the studies have contributed to our understanding of II in relation to PI, 
indicating that II is a lifelong disorder, with a possible physiological basis. Previous research 
has also suggested that individuals with II are more likely to use denial as a coping 
mechanism. However, the main finding was that adults with II were less likely to respond to 
behavioural treatment for insomnia. This is understandable as individuals with PI are more 
likely to respond to behavioural interventions that encourage unlearning of sleep-preventing 
associations. Alternatively, adults with II are unlikely to respond to a treatment which does 
not take account of the unrelenting nature of the disorder or physiological differences that may 
be present. It may therefore be important to consider alternative ways of managing II.
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Management of Idiopathic Insomnia
In acknowledging that II is an unrelenting condition, it may be worthwhile to conceptualise 
this particular subtype within a chronic disease framework. A chronic disease is defined as 
‘persisting beyond the point at which healing would be expected to be complete or that occurs 
in disease processes in which healing does not take place ’ (Scottish Executive, 2004). Health 
conditions such as chronic pain and chronic fatigue syndrome share similar features with 
idiopathic insomnia. Disorders are poorly understood psychophysiological conditions often 
displaying poor treatment response (Van Damme et al., 2006; McCracken et al., 2005). In 
addition, the literature acknowledges the frustration and helplessness the clinician frequently 
experiences when working with such groups (Figley, 2002).
Research conducted with patients experiencing chronic health problems have demonstrated 
that individuals report better psychological outcomes when clinicians adopt the perspective 
that healing as opposed to treatment is required “Strictly speaking, the question is not how to 
be cured but how to live” (Conrad quoted in Brown, 2002 (ppl448). Studies have also shown 
that factors such as coping style and illness-related beliefs are associated with psychological 
functioning (Arena, 2002). When working with patients diagnosed with a chronic illness, 
psychologists are encouraged to be flexible in their approach to therapy (Imes et al., 2002) and 
to consider alterative approaches such as mindfulness-based (Brown, 2002) or acceptance- 
based treatments (McCracken et al., 2004). Such therapies promote acceptance and reduce the 
psychological distress that is often associated with searching for a cure. Therefore if II was 
considered a chronic illness, the aim of psychological therapy would be to promote insomnia 
acceptance.
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The role o f acceptance
Acceptance is a difficult concept to define. Researchers have explored acceptance both in 
terms of mental and cognitive processes that occur within the individual and as an 
acknowledgement that the disorder is a chronic condition, for which there is no cure. An 
acceptance-based approach encourages the individual to realise that meaningful life can be 
achieved and aims to promote engagement in purposeful activities. The purpose is to 
encourage the individual to shift focus from disorder-specific aspects of life, to non-disorder 
aspects of life. The desired clinical outcome would be increased psychological well-being, as 
opposed to symptom alleviation. Therefore the desired outcome in II would be accepting this 
particular subtype of insomnia as an unrelenting condition and reduce the energy and distress 
that is consumed by trying to control and cure insomnia.
The role of acceptance has become an important psychological concept in a range of medical 
and psychological disorders. Associations between acceptance of the disorder and 
psychological well-being have been observed in borderline personality disorder (Linehan, 
1993); pain (McCracken et al., 2005; McCracken and Eccleston, 2005); chronic fatigue 
syndrome (Van Damme et al., 2006); HIV and AIDS (Giza-Zwierzchowska, 2005).
To date, three studies have considered the use of acceptance in terms of cognitive and mental 
processes in individuals with insomnia (Lundh, 2005). Shapiro et al. (2003) examined the 
effects of mindfulness-based training on thirty-one females with breast cancer. Compared to a 
control group, patients who received a mindfulness intervention reported improvement in 
sleep quality, which was related to a decrease in cognitive activity. Heidenreich et al. (2006)
56
used a mindfulness approach on patients with PI. Although this study lacked adequate power 
and a control group, results showed that this approach reduced sleep latency. Finally Yook et 
al., (2008) reported that mindfulness-based cognitive therapy was effective for treating 
insomnia that was secondary to anxiety. In addition, studies examining thought suppression 
and worry in insomnia, demonstrate that trying to control and avoid associated thoughts can 
have a paradoxical effect (Broomfield and Espie, 2003).
The author is not aware of previous research examining the effect of acceptance in terms of 
acknowledging insomnia as an unrelenting condition. However, it is proposed that adults with 
II would be more accepting of their condition, given the perceived lack of controllability they 
may experience and possible belief that their insomnia is a lifelong condition.
The role o f  treatment preference in Idiopathic Insomnia
In proposing an acceptance-based intervention for II, it would be informative to investigate 
patients’ acceptance of this approach. The Treatment Acceptability Scale (TAS) for insomnia 
was developed by Morin et al. (1992) to examine the acceptance of psychological treatment 
for insomnia and to explore if acceptability of treatment influenced treatment-seeking 
behaviour and adherence. He argued that regardless of the efficacy of a particular treatment, it 
would be of little clinical use if it were not acceptable to patients. The TAS describes 
behavioural treatment and pharmacological treatment for insomnia. The behavioural 
treatment is described as a self-management programme for changing poor sleep habits, 
regulating sleep schedules and improving sleep hygiene. The pharmacological treatment is 
described as medication that induces sleep by reducing physiological and cognitive arousal.
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Participants are asked to rate scales examining the following: treatment acceptance, 
willingness to comply, suitability fo r  sleep onset and maintenance problems, perceived 
effectiveness and side effects associated with each treatment.
Morin et al. (1992) asked seventy-one older adults with insomnia to complete the TAS and 
reported that that the majority of patients gave a higher acceptability score to behavioural 
therapy in comparison to pharmacological treatment. Research has suggested that older adults 
may be inclined to assume that their sleep difficulties stem from physical problems and are 
more likely to take a passive role in treatment (Charlesworth and Greenfield, 2004) hence the 
results of the aforementioned study may hold more weight.
In proposing an acceptance-based approach for insomnia, the TAS could be adapted to include 
an acceptance-based option. As this approach may be more beneficial for adults with II, it 
would be important to investigate if acceptability ratings were higher in this group.
In light of findings previously discussed, the current study aimed to explore potential 
differences in the way adults with PI and adults with II conceptualise their sleep difficulties. 
This study therefore looked to compare sleep perceptions, level of acceptance, coping style, 
and treatment acceptability in a sample of adults with PI and a sample of adults with II.
It was hypothesized that adults with II would view their sleep difficulties to be more 
permanent and uncontrollable in comparison to adults with PI. It was expected that adults 
with II would be more accepting of their insomnia, due to the duration of their difficulties.
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Based on previous research, it was predicted that adults with II would be more likely to report 
coping styles which reflect ‘denial’ in comparison to participants with PI. Finally, it was 
envisaged that whilst behavioural therapy would achieve a higher acceptability rating than 
pharmacological treatment and an acceptance-based approach, adults with II would rate an 
acceptance-based approach higher than adults with PI. Secondary hypotheses were also 




The aim of this present study was to examine potential differences in the way adults with PI 
and adults with II conceptualise their sleep difficulties, and consider the wider implications for 
the clinical management of insomnia.
Hypotheses
Primary hypotheses:
1) Participants with II will perceive their sleep difficulties to be more permanent in 
comparison to participants with PI.
2) Participants with II will report less control over their sleep difficulties when compared 
to participants with PI.
3) Participants with II will be more accepting of their insomnia in comparison to 
participants with PI.
4) Participants with II will be more likely to report using ‘denial’ as a coping style in 
comparison to participants with PI and good sleepers.
5) Participants with II and participants with PI will rate behavioural treatment as more 
acceptable than pharmacological and acceptance-based treatment. However 
participants with II will be more likely to rate an acceptance-based approach as more 
acceptable than pharmacological treatment.
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Secondary hypotheses:
6) Regardless of insomnia subtype, participants will be more accepting of an acceptance- 
based treatment if they view their insomnia as permanent.
7) Regardless of insomnia subtype, participants more accepting of their insomnia, will 




Ethical approval was granted by NHS Greater Glasgow Primary Care Division; University of 
Strathclyde; and University of Glasgow Faculty of Medicine (appendix 2.4). Written 
informed consent was obtained from all participants (appendix 2.7).
Design
The present study was a cross sectional between-groups design with three groups: Normal 
Sleepers (NS), adults with PI and adults with II. The primary dependant variables in relation 
to the above hypotheses were: the timeline perceptions domain of the Illness Perception 
Questionnaire-Revised (IPQ-R); the acceptance scale of the Illness Cognition Questionnaire 
(ICQ); the personal control scale and treatment control scale of the IPQ-R; the Brief COPE 
(BC); the Treatment Acceptability Scale (TAS); and the Short Form Health Survey 
Questionnaire-36 (SF-36). Group was the main independent variable.
Participants
Inclusion and exclusion criteria
To be included in the II group and PI group, participants were required to meet ICSD-2 
criteria (table 2). The NS group were required to meet research diagnostic criteria for normal 
sleepers, as recommended by the American Academy of Sleep Medicine Work Group 
(Edinger et al., 2004). This required the individual to have no complaints of sleep disturbance 
or daytime symptoms attributable to unsatisfactory sleep. To ensure the PI group and II group
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were clearly defined; insomnia onset was required before 10 years of age for the II group, and 
following 18 years of age for the PI group.
Participants were excluded from the study on the basis of the following: meeting criteria for 
other sleep disorders such as narcolepsy, sleep apnoea, restless legs syndrome, circadian sleep 
disorders or parasomnias; showing evidence of mood disorder; showing evidence of substance 
abuse; receiving psychotherapy; experiencing a somatic disorder; taking prescribed 
medication that was influencing sleep.
Power calculation
As there were no published studies which have examined the chosen outcome measures 
between adults with II and PI, guidance was based on the studies previously discussed that had 
explored differences between PI and II. Hauri and Olmstead (1980) found significant 
differences between PI (n = 39) and II (n = 20) in terms of sleep duration (p = .05), longer 
sleep latency (p = .04) and abnormal REM (p = .03), Hauri (1983) found significant 
differences in terms of coping strategies observed between adults reporting PI (n = 10) and 
adults reporting II (n = 12); meanwhile Edinger et al. (1988) found significant differences in 
terms or scores obtained from the MMPI and treatment response. However, a power 
calculation could not be performed based on these studies as Hauri and Olmstead (1980) were 
examining physiological aspects of sleep, and Hauri (1983) and Edinger et al. (1988) did not 
report data required to perform a power calculation.
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Therefore taking sample sizes of pervious studies into account, it was calculated that the 
present study would require thirty participants in each group to detect significant differences 
between groups. According to Cohen (1992) this size of sample should typically produce a 
medium to large effect size on a t-test. Introducing robust diagnostic criteria for NS, PI and II 
would also increase the power of this study.
Procedure
Participants were volunteers who responded to a university e-mail or posters that had been 
placed in GP surgeries, hospitals and work-based canteens (appendix 2.5). This was part of a 
wider recruitment campaign for a number of studies that were being carried out at the 
Glasgow Sleep Centre (Sackler Institute of Psychobiological Research, Southern General 
Hospital, Glasgow). A screening protocol operated over two stages.
Screening stage 1:
Potential participants were screened initially by email or telephone interview. The telephone 
interview lasted an average of ten minutes. During this, participants were asked to briefly 
describe their sleep difficulties in relation to exclusion and inclusion criteria and participants 
were provided with information about the research process. A Participant Information Sheet 
(appendix 2.6) which provided a brief written summary was dispatched to potential 
candidates. Individuals not meeting inclusion criteria at this point were debriefed and 
informed of other research studies taking place at the Glasgow Sleep Centre. Upon receiving 
the Participant Information Sheet, participants were instructed to contact the researcher if they
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still wished to take part. Following this an appointment letter and 7-day sleep diary was 
dispatched to participants.
Screening stage 2
Participants met the researcher at the Glasgow Sleep Centre. The second part of the process 
involved participants completing a consent form (appendix 2.7) screening measures and taking 
part in a brief semi-structured interview. This lasted between thirty to forty-five minutes and 
also included a review of participants’ sleep diary. Participants not meeting inclusion criteria 
at this point were debriefed and informed of other research studies taking place. Reasons for 
exclusion at this stage were mainly due to delayed sleep phase, or the presence of anxiety, 
depression or substance use disorder.
Research procedure
If inclusion criteria were satisfied based on the above, participants were then left alone to 
complete experimental measures. The time required to complete the measures was between 
twenty to thirty minutes. Following completion, participants were fully debriefed about the 
aims of the study and thanked for their participation. They were also asked if they wished to 
receive feedback regarding the findings of the study. Data were then coded and analysed 
using the Statistical Package for the Social Sciences (SPSS). Allocation of participants to 
groups did not occur until data were collated from the clinical interview, screening 




The screening measures used to ensure that participants met inclusion criteria and were 
allocated to the correct group were: University of Glasgow Structured Interview for Sleep 
Disorders (SIS); Beck Depression Inventory II (BDIII); Beck Anxiety Inventory (BAI); 
Pittsburgh Sleep Quality Index (PSQI); Insomnia Severity Index (ISI); Beliefs and Attitudes 
about Sleep Scale - 16 (DBAS-16); 7-day sleep diary.
1) The SIS has been developed to obtain demographic information, and to assess if 
participants met criteria for II or PPI. This semi-structured interview was also used to 
identify and exclude participants on the basis of other sleep wake disorders, drugs and 
alcohol misuse, physical or mental health problems that could be causing sleep 
difficulties. The interview required a degree of clinical judgement which provided an 
alternative to self-report data.
2) The BDI-II was used as self-report measure of depression. It is a 21-item measure 
reporting a high test-retest correlation of 0.93 and a reported internal consistency 
Cronbach’s alpha of 0.91 (Beck et al., 1996). A cut-off score of 20 or above suggests 
moderate to severe depression. Participants obtaining a score of 20 or above were 
excluded.
3) The BAI (Beck et al., 1988) was used as self-report measure of anxiety. This is a 21- 
item measure reporting a test-retest correlation ranging from 0.35 to 0.83 and high
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internal consistency Cronbach’s alpha of at least 0.83 (De Ayala et al., 2005). Scores 
above 16 indicate moderate to severe anxiety. Participants obtaining a score of 16 or 
above were excluded.
4) The PSQI (Buysee et al., 1989) is a likert scale self-report measure of sleep quality and 
patterns of sleep. This measure provided information on sleep characteristics and was 
used to support diagnosis and group allocation. The score on the PSQI has been shown 
to discriminate between normal and poor sleepers, with a diagnostic sensitivity of 
89.6% and specificity of 86.5%. A score of 5 or less is suggestive of a normal sleep 
pattern.
5) The ISI (Morin, 1993) is a self-report measure that was used to support group 
allocation and provide information on sleep characteristics of participants. This brief 
measure is designed to assess the daytime effects of insomnia, sleep satisfaction and 
the level of distress experienced as a consequence of insomnia. It has adequate 
internal consistency Cronbach’s alpha of 0.74 (Bastien et al., 2001). A score of 10 or 
more is suggestive of insomnia.
6) The DBAS-16 (Morin et al., 2003) contains 16 statements paired with a 10-point 
analogue scale for the responder to rate whether they strongly agree or disagree with a 
particular statement. This questionnaire was used to measure: sleep expectations, sleep 
related worry, beliefs about the consequences of insomnia and level of helplessness 
associated with sleep. The DBAS-16 has a reported internal consistency Cronbach’s
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alpha of 0.77 and temporal stability of 0.83 (Morin et al, 2007). This measure was 
used to elicit beliefs and attitudes about sleep. High scoring on the DBAS-16 indicates 
a higher prevalence of dysfunctional beliefs about sleep.
7) Participants were also asked to complete a sleep diary for seven days. Data from the 
diary were reviewed to ensure participants met inclusion criteria for insomnia and there 
was no evidence of delayed sleep onset. Participants failing to meet criteria for 
insomnia based on information obtained from sleep diaries were excluded.
Measures fo r  hypothesis testing (appendix 2.8):
Hypothesis 1
The timeline perceptions domain of the IPQ-R (Moss-Morris et al., 2002) includes a timeline: 
acute /  chronic subscale (6 items) which measures individuals’ perceptions of permanency 
(e.g. "my illness is likely to be permanent rather than temporary 7  expect to have this illness 
fo r  the rest o f  my life ’)  and a timeline: cyclical subscale (4 items), which measures if an 
individual perceives their illness to have a cyclical nature or perceives their insomnia to be 
constant and unrelenting (e.g. 7 go through cycles in which my illness gets better and worse 
‘my illness is very unpredictable ’). Participants are asked to respond using a 5-point likert 
scale ranging from ‘strongly disagree’ to ‘strongly agree’.
In this study the word illness was replaced with insomnia prior to administration and was only 
administered to the PI group and the II group. This tool has previously been adapted to suit
68
particular health populations and has an internal consistency Cronbach’s alpha ranging from 
0.70 to 0.90 (Moss-Morris et al., 2002).
Hypothesis 2
The personal control subscale (6 items) and treatment control subscale (5 items) of the IPQ-R 
was used to elicit individuals’ beliefs in relation to having personal control over their illness 
(e.g. 'I  have the power to influence my illness ’) or if they believe treatment will be effective in 
curing their illness (e.g. ‘ There is nothing which can help my condition
The ICQ -  helplessness scale (Evers et al., 2001) was used as an additional measure of 
control. In this study the word illness was replaced with insomnia prior to administration. 
Helplessness statements (6 items) include ‘my illness controls my life’ and ‘my illness limits 
me in everything that is important to me ’. Validation studies have shown the ICQ to be a 
reliable and valid assessment of perceptions of patients with a chronic disease, reporting an 
internal consistency Cronbach’s alpha ranging from 0.84 to 0.91 (Evers et al., 2001). This 
measure was only administered to the PI group and II group.
Hypothesis 3
The ICQ-acceptance scale (6 items) was used to measure participants’ acceptance of insomnia. 
Acceptance statements include: “I  think I  can handle the problems related to my insomnia, 
even i f  the insomnia gets worse ” and “I  can cope effectively with my insomnia ”. A high score 
on this scale is indicative of low acceptance. This measure was only administered to the PI 
group and II group.
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Hypothesis 4
The BC (Carver, 1997) is a 28-item questionnaire made up of 14 subscales which assess the 
following coping reactions: active coping, planning, positive refraining, acceptance, humour, 
religion, using emotional support, using instrumental support, self-distraction, denial, venting, 
substance use, behavioural disengagement, and self-blame. This measure was chosen for the 
breadth of coping reactions examined. The BC  has been applied in a number of health related 
studies and subscales have an internal reliability Cronbach’s alpha ranging from 0.50 to 0.90. 
This measure was used to explore participants’ general coping strategies.
Hypothesis 5
The original TAS (Morin et al., 1992) was adapted to include a third ‘acceptance treatment’ 
option. This was described as a nondrug treatment method, aimed at encouraging acceptance 
of insomnia and consisting of strategies for overcoming the impact that insomnia has on life. 
Participants were asked to consider each of the methods (behavioural treatment, 
pharmacological treatment and acceptance treatment) as potential treatment options and to 
give a rating in terms of support, willingness, effectiveness and suitability. Sub scores are 
combined to produce a total acceptability score for each treatment. The original scale has a 
high internal consistency Cronbach’s alpha 0.87 for the pharmacological scale and 0.80 for the 
behavioural scale (Vincent and Lionberg 2001).
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Hypothesis 6
The IPQ-R acute-chronic scale and IPQ-R cyclical scale was used to measure individuals’ 
perception of permanency. The TAS acceptance treatment scale was used to describe 
acceptance based treatment.
Hypothesis 7
The SF-36 has a mental and physical subscale. This was used to measure quality of life.
Items are scored from 0 to 100, with a higher score indicating better health. Available data on 
the reliability of this measure shows the SF-36 tends to exceed 0.80 (Ware et al., 1993). The 
acceptance scale of the ICQ was used to measure insomnia acceptance. In addition, the 
acceptance subscale of the BC  was used to examine if participants employing ‘acceptance’ as 
an everyday coping strategy were more likely to report a higher quality of life.
Statistical Analysis
Analysis was conducted using the Statistics Package for the Social Sciences for Windows 
(SPSS for Windows version 15). All data were checked using graphical and numerical 
methods. To ensure suitability for parametric testing, Kolmogorov -Smirnov tests were 
applied to statistically test normality. Due to the exploratory nature of this study and potential 
for Type II error, an alpha level of .05 was initially employed for all statistical tests (two- 
tailed). This was later adjusted to correct for multiple comparisons using the Bonferroni 
adjustment procedure. When appropriate, data not normally distributed were transformed 
using the Square-root transformation for normalizing moderately skewed data (Tabachnik and 
Fidell, 1996). This ensured data satisfied assumptions for parametric testing.
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One-way ANOVA, Independent Samples t-tests, Chi squared tests and Correlation analyses 
were used to compare groups. Related t-tests were used to examine treatment acceptabilty 
within each group. The internal consistency of experimental scales was measured using 
Cronbach’s alpha.
Summary statistics were used to describe the sample in terms of demographic, clinical and 
sleep characteristics. If group differences were identified, then it was considered as a 




On the basis of inclusion criteria and screening measures 31 participants were categorised as 
normal sleepers (NS), 31 participants were categorised as adults with PI, and 30 participants 
were categorised as adults with II. All participants were of white European ethnic origin. A 
small percentage of participants were excluded on the basis of mood disorder (n = 5) and 
evidence of delayed sleep onset (n = 3). Demographic characteristics and between-group 
comparisons are presented in Table 3.
[Insert Table 3 here]
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With regards to group differences in demographic data, ANOVA and Tukey’s post-hoc Test 
demonstrated that the PI group were significantly older than the NS group. Chi-square 
indicated that there were no gender differences between groups. The NS group were more 
likely to have attended university or college and be in a relationship. No significant 
differences were found between the PI group and II group.
In relation to educational achievement and relationship status, differences between the NS 
group and experimental groups were representative of previous findings reported in the 
literature (Ohayon, 1996; Sutton et al., 2001). Since age was identified as a possible 
confounding variable, each of the analyses used to test study hypotheses involving good 
sleepers were performed first without a covariate and then again with an analysis of 
covariance (ANCOVA), with age as a covariate (appendix 2.9). This did not change the 
pattern of results.
[Insert Table 4 here]
Clinical and Sleep characteristics
Summary data and between group comparisons of clinical and sleep characteristics of 
participants are presented in Table 4. There were no significant differences between groups in 
terms of alcohol use. The NS group obtained lower scores on the B D III and BAI in 
comparison with the PI group and II group. As would be expected, the NS group reported 
fewer sleep difficulties than the PI group and II group as measured by ISI, PSQI and
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DBAS-16. There were no significant differences between the PI group and II group on 
reported clinical and sleep difficulties. Data on sleep characteristics confirmed group 
allocation.
The mean scores obtained from the ISI and PSQI indicated that adults were experiencing 
insomnia of moderate severity. The average duration of insomnia was 7 years for the PI group 
and 26 years for the II group. In terms of previous treatment for insomnia, none of the 
participants reported previous psychological treatment. All participants reported occasional or 
previous use of prescribed and non-prescribed medication for insomnia, though none were 
taking prescribed medication at time of assessment.
Scale descriptives
Scale descriptives for measures used to test the study hypotheses are reported in appendix 
2.10. Internal consistency was acceptable for all scales except IPQ-R treatment control (0.68). 
Previous studies have obtained 0.80 (Moss-Morris et al., 2002). When this scale was checked 
to see if internal consistency improved following deletion of particular items, the removal of 
IPQ-R-19 ''There is very little that can be done to improve my insomnia ’ resulted in a 
Cronbach’s alpha of 0.71. However this item was not removed, as it would have produced a 
4-item scale, thus reducing the reliability of the measure.
The TAS acceptance scale was specifically developed for the purpose of this study. This scale 
achieved a high internal consistency of 0.92. Correlation analyses indicated this was not 
related to ICQ - acceptance (r = -.065; p = 0.64) or BC- acceptance (r = -.07; p = 0.62)
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suggesting items are measuring different concepts. The internal consistency of BC subscales 
was not checked, as each scale was constructed of two items only.
Testing the study hypotheses
Table 5 displays inferential statistics and between group comparisons for all self report 
measures that were used for hypothesis testing.
[Insert Table 5 here]
Hypothesis 1:
Both groups generally perceived their sleep difficulties to be permanent, scoring above the 
mid-point on the IPQ-R acute /  chronic subscale. However the II group scored significantly 
higher, indicating that this group viewed their insomnia to have greater permanency.
However, after controlling for multiple comparisons (critical value of < .025), this difference 
was marginally non-significant. A retrospective power calculation was performed indicating 
that a sample size of 50 participants in each group would be required to detect meaningful 
differences if they were present. There was no significance difference between groups on IPQ 
-  cyclical subscale. Both groups tended to neither agree nor disagree that their insomnia had a 
cyclical nature or that their insomnia was unrelenting. Hypothesis 1 was partially supported.
Hypothesis 2:
No significant differences were obtained between the PI group and the II group on the 
following: IPQ-R -personal control subscale; the IPQ-R - treatment control subscale and ICQ
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-  helplessness scale. There was no evidence to suggest that the PI group believed they had 
more control over their sleep difficulties in comparison to the II group. Hypothesis 2 was not 
supported.
Hypothesis 3:
Both groups scored high on the ICQ -  acceptance subscale, indicating a low level of insomnia 
acceptance. However there were no significant differences between participants with PI and 
participants with II in relation to insomnia acceptance. As p = 0.17, a retrospective power 
calculation was performed indicating that a sample size of 110 participants in each group 
would be required to detect meaningful differences. Hypothesis 3 was not supported.
Hypothesis 4:
The II group were not more likely than the NS group and PI group to use denial as a coping 
mechanism. Differences were however observed in the following three dimensions: 
acceptance, self distraction and humour. The NS group were less likely to cope with 
difficulties through acceptance when compared to the II group. The II group were more likely 
to employ self-distraction and humour as coping mechanisms in comparison to the PI group 
and NS group. When corrected for multiple comparisons (critical value of < 0.004) this was 
only significant for humour. Hypothesis 4 was not supported.
Hypothesis 5:
There were no significant differences between the PI group and the II group in relation to 
ratings for behavioural treatment and pharmacological treatment was marginally non­
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significant. There were significant differences between groups in terms of ratings for an 
acceptance-based approach to insomnia. The II group rated acceptance based treatment as 
more acceptable than the PI group. This retained significance after controlling for multiple 
comparisons (critical value of < 0.02). Treatment acceptability scores for the PI and II groups 
are illustrated in Figure 1. Related t tests indicated that behavioural treatment was the highest 
rated for the PI group [behavioural vs. pharmacological: t(31) = 3.3;p = .003; behavioural vs. 
acceptance: t (31) = 5.03; p < .001] and II group [behavioural vs. pharmacological: t (30) = 
3.45; p = .002; behavioural vs. acceptance: t (30) = 2.79; p = .01]. Hypothesis 5 was 
supported.
Hypothesis 6:
Pearson correlation coefficients conducted between TAS -acceptance and IPQ-R acute /  
chronic; and TAS -acceptance and IPQ-R cyclical indicated that participants who perceived 
their insomnia as more permanent were unlikely to rate an acceptance treatment higher [{TAS 
acceptance* IPQ-R acute / chronic: r(61) = .17; p = .21), (TAS-acceptance*IPQ-R chronic: 
r (61) = -.05; p = .74)/. Hypothesis 6 was not supported.
Hypothesis 7:
Pearson correlation coefficients conducted between SF-36- M H and ICQ-acceptance; and SF- 
36-PH and ICQ-acceptance were also non-significant: [{SF36-MH*ICQ-acceptance: r (61) = - 
.10 p = .46), (ICQ-acceptance* SF36-PH: r (61) = .23; p = .09)]. Hypothesis 7 was not 




As the II group were more likely to employ humour as a coping strategy, a secondary analysis 
was conducted to examine the relationship between ICQ-acceptance and BC-humour. 
Although Pearson correlation coefficients identified a significant relationship for the PI group 
(r = .591; p = .002) this pattern was not observed for the II group (r = 0.76; p = .75).
DISCUSSION
The present study was the first diagnostically robust comparison between PI and II. This 
study initially examined if insomnia subtypes differed in the way sleep difficulties were 
conceptualised and accepted in PI and II. Secondly, it offered a preliminary theoretical 
approach for understanding and managing II. The main results will be discussed before study 
strengths and weaknesses are examined.
Beliefs about insomnia
Participants in both the PI and II groups were selected on the basis of having persistent 
insomnia. Both groups obtained comparable scores in relation to self-report measures of 
insomnia severity and sleep quality. Findings indicate that subjective accounts of sleep 
disturbance were similar for PI and II, however sleep related beliefs were significantly 
different for NS. Whilst these outcomes are consistent with findings reported by Philip and 
Guilleminault (1996), they are inconsistent with previous research looking at sleep related 
thoughts. Previous researchers using the DBAS-16 have reported that normal sleepers can 
often report similar sleep related beliefs to people with insomnia, including beliefs about 
compensatory napping and staying in bed whilst unable to sleep (Ellis 2007). However, it is
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worth noting that separate analyses for each item of the DBAS-16 were not performed and this 
may account for findings in this current study.
Both groups rated their insomnia as chronic on the IPQ-R acute/chronic scale. However, in 
relative terms, and as predicted, there was evidence that the II participants viewed their sleep 
problem as more permanent and lifelong. Although this effect was marginally non-significant 
following conservative correction, it nonetheless is suggestive of a differing perspective in this 
group. This could have implications for their expectations of therapy and /or therapeutic 
outcomes.
It had also been predicted that the II group would perceive their insomnia to be more constant 
and unrelenting, whereas the PI group would be able to report some periods of normal sleep. 
Results on the IPQ-R cyclical subscale however revealed more similarity than expected. In 
accounting for this finding, the validity of the scale used to measure participants’ perceptions 
of insomnia was considered. The IPQ-R instructed participants to report current views of 
insomnia. It may be the case that adults participating in sleep research are likely to view their 
insomnia as constant and unrelenting at that present moment in time. In addition, the PI group 
were a chronic sample, reporting an average insomnia duration of seven years. Perhaps 
adapting the measure to ask participants to reflect about their sleep difficulties ‘over a longer 
period’ would have resulted in observed differences between groups.
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Treatment acceptability
When participants were asked to rate their acceptability of a behavioural, pharmacological and 
acceptance-based approach for insomnia, both groups gave a higher acceptability rating for the 
behavioural approach. This replicated previous findings about the acceptability of behavioural 
treatment for insomnia (Morin et al., 1992) and provides further support for cognitive- 
behavioural treatment as the treatment of choice for patients as well as clinicians (Espie,
1999).
As previously discussed, taking account of patients’ preference and expectations is critical in 
terms of choosing treatment options. However, the observation that behavioural treatment 
obtained the highest acceptability score in the II group has important clinical implications, as 
Edinger et al. (1988) found that individuals with II are unlikely to respond to behavioural 
treatment. Whilst controlled treatment trials would firstly be required to replicate findings 
reported by Edinger et al. (1988), recommending this approach may cause further 
psychological distress to adults with II. It is therefore of considerable interest that the II group 
rated an acceptance-based approach as more acceptable than the PI group. Although non­
significant the II group rated acceptance treatment higher than pharmacological treatment.
However it is important to note that the measure used to assess treatment acceptability did not 
ask participants to rank treatments in order. Instead treatment ratings were made independent 
of other treatment options. Thus, participants were not forced to choose which treatment was 
most acceptable out of the three options. Further research using a measure which specifically 
requires individuals to rank treatment, would provide a truer indication of preference.
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Nevertheless, it may be envisaged that a higher acceptability score could be predictive of 
actual preference in clinical practice. This allows preliminary consideration of an acceptance- 
based approach for II.
Acceptance o f insomnia
Consistent with the expectation that an acceptance-based approach to treatment might be 
appropriate for II, it was predicted that participants with II would report higher levels of 
insomnia acceptance in comparison to adults with PI. However, findings indicated that neither 
group found their insomnia acceptable. This may be indicative of the fact that participants 
were people who, by definition, had insomnia complaints. Nevertheless the finding is not 
necessarily in conflict with openness to an acceptance-based treatment, specifically in the II 
group. Perhaps recognition of the value of acceptance is more evident to those who are non­
accepting yet realise that their condition is likely to be permanent.
The fact that neither group found their insomnia acceptable, may explain the minimal 
association that was observed between acceptance and quality of life which has been reported 
in chronic health conditions such as chronic pain (McCracken et al., 2004) and chronic fatigue 
syndrome (Van Damme et al., 2006). In addition, it should also be noted that the ICQ- 
acceptance scale was a cognitive measure of acceptance, whereas acceptance may be observed 
behaviourally, and fluctuate over time (Vianne et al., 2003). Therefore prior to developing an 
acceptance-based treatment for insomnia, a comprehensive assessment of insomnia acceptance 
is required to examine if increasing insomnia acceptance does actually reduce psychological 
distress and impact on quality of life.
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Research examining acceptance within chronic pain may provide guidance for developing an 
insomnia acceptance measure. As previously stated, the nature of II bears some resemblance 
to chronic pain. The Chronic Pain Acceptance Questionnaire (McCracken et al., 2004) is an 
instrument that explores the degree to which the patients behaviour is free from the influences 
of pain. Validation studies have shown that the pain willingness and activity engagement sub­
components of this measure are significant predictors of acceptance and adjustment in chronic 
pain (McCracken et al., 2004; McCracken and Yang 2006). Whilst this measure has been 
criticized for failing to recognize cognitive variables that may also account for acceptance to 
chronic pain (Nicholas and Asghari, 2006), it may prove to be a useful starting point for 
developing a measure of insomnia acceptance.
Humour
An unexpected finding of the study was that adults with II were more likely to report humour 
as a coping mechanism than normal sleepers and adults with PI. Humour is believed to reduce 
stress in health conditions (Imes et al., 2002) and the relationship between humour and 
psychological wellbeing (‘if I do not laugh I will cry’) is widely accepted. However Bennet 
and Lengacher (2006) investigated the relationship between humour and health and found 
there were limited studies providing empirical data in support of this relationship.
Nevertheless, previous research has indicated that adults with II tend to show normal 
psychological profiles (Hauri, 1983; Edinger et al., 1988). Therefore it may be possible that 
humour is acting as a buffer against psychological distress. Whilst clinicians need to validate 
the emotional suffering adults with chronic insomnia experience, humour may be an important
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psychological tool for coping with insomnia. Bromfield and Espie (2003) have shown that 
paradoxical intention approaches for insomnia (e.g. instructing patients to concentrate on 
staying awake as opposed to trying to sleep) can result in a reduction of sleep effort and sleep 
performance anxiety known to perpetuate insomnia (Espie, 2002). This method can sometimes 
require a humorous approach to intervention.
In conclusion, the main findings of this study were that adults with II may perceive their sleep 
difficulties to be more permanent than adults with PI. In terms of treatment application, an 
acceptance-based approach may by an alternative to CBT for II.
Clinical Implications
The findings obtained from this study have a number of important clinical implications for the 
psychological treatment of insomnia and insomnia subtypes. First of all this study was able to 
identify and differentiate between PI and II. This finding requires further exploration of 
developmental pathways and response to psychological treatment for insomnia subtypes, 
especially in relation to II. An insomnia subtype, which so far has received little attention in 
the sleep literature. Secondly, this study has shown that insomnia subtypes differ in relation to 
how they view and conceptualise their sleep difficulties, suggesting that adults with II may be 
more likely to accept an acceptance-based approach for coping with their sleep difficulties, 
whereas adults with PI are more likely to accept a pharmacological approach, which focuses 
on reducing symptoms. This suggests that there may be differences concerning treatment 
outcomes and therapeutic approaches for insomnia subtypes.
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Whilst this is a preliminary study, it suggests that further research on insomnia subtypes is 
warranted, with the possibility of developing alternative psychological approaches for 
managing II. The introduction on an acceptance-based approach for sleep difficulties would 
therefore require an acceptance-based approach for insomnia to be developed and standardised 
and for alternative clinical outcomes to be determined.
Strengths and Weaknesses
The main strength of this study was that groups were defined according to strict diagnostic 
criteria for II and PI. Although this was not intended to be a validation study of insomnia 
subtypes, the findings do provide empirical support for distinguishing between PI and II. It 
should also be noted that identification of an II subtype was not as challenging as the sleep 
literature would suggest. Therefore it is surprising that that this group has rarely been 
evaluated.
Nonetheless, there are a number of weaknesses which limit the generalization of findings. 
Firstly, the sample consisted of adults reporting insomnia of moderate severity as indicated by 
scores obtained from the ISI and PSQI. Therefore results cannot be generalised to severe PI 
and II.
Secondly, the study may have been vulnerable to Type II error. As this was a novel study, the 
researcher had limited information for determining a sample size that would ensure significant 
differences between groups would actually be detected. Whilst retrospective power 
calculations suggested that significant results might have been obtained in a larger sample,
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there is no current evidence to support this assumption and further research is required. 
Nevertheless, this study does provide some guidance for future research in relation to sample 
size.
Thirdly, and as previously discussed, a limitation was the validity of self-report measures. 
Items selected for assessing permanency and acceptance did not in retrospect, encompass the 
complex and multidimensional nature of these concepts. However, this was the first study 
known to adapt measures for this population and high internal consistency was achieved.
In addition, the TAS was also adapted for this study to incorporate an acceptance-based 
approach to treatment. Whilst this option was designed to mirror the style and format of the 
behavioural and pharmacological treatments defined by Morin et al. (1992), the questionnaire 
was not piloted prior to administration. This may have contributed to an uncontrolled bias for 
an acceptance-based approach. Furthermore, all participants were asked to rate behavioural 
treatment first and acceptance treatment last. Therefore the behavioural treatment score was 
the baseline treatment for which other options were considered. Randomization of treatment 
options may have increased methodological rigor.
Another limitation of self-report measures is that the II group may have been unable to 
provide accurate accounts of insomnia onset. Although this group were asked about 
psychosocial factors around the time of onset, it would have been beneficial to have obtained a 
developmental history from a caregiver.
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Finally, findings from the literature have suggested that adults with the II could have higher 
arousal (Edinger et al, 1988). It would therefore have been beneficial to include a measure of 
arousabilty to validate previous findings, and explore the relationship between arousabilty and 
sleep perceptions within PI and II.
Conclusion
This study was an exploratory study examining differences between PI and II. A number of 
important findings were generated, indicating that there is a requirement for further 
understanding of insomnia subtypes. Perhaps the most important finding was that a number 
of approaches may be acceptable to adults with insomnia.
In addition, two areas of future research have also been identified. Firstly, research should 
investigate if a differential response to psychological treatment for insomnia can be 
determined by insomnia subtype. Secondly, validation of an acceptance-based approach as an 
effective intervention for II is required. Both could be addressed in a randomised controlled 
trial (using subtypes as a randomization factor) that compares cognitive-behavioural therapy 
with a clearly distinguished acceptance-based approach for primary insomnia.
At present, clinicians need to be aware of the variation within insomnia subtypes. A flexible 
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Table 1: Criteria for the Diagnosis of Primary Insomnia
DSM -IV Diagnostic Criteria for Insom nia ICSD-2 Diagnostic Criteria for Insomnia
• The predominant symptom is difficulty initiating or • A Complaint o f  difficulty initiating sleep, difficulty
maintaining sleep, or nonrestorative sleep, for at maintaining sleep, or waking up too early, or sleep that is
least 1 month. chronically nonrestorative or poor in quality.
• The sleep disturbance (or associated daytime
fatigue) causes clinically significant distress or 
impairment in social, occupational, or other 
important areas o f functioning.
• The sleep disturbance does not occur exclusively
during the course o f narcolepsy, breathing-related 
sleep disorder, circadian rhythm disorder or a 
parasomnia.
• The disturbance does not occur exclusively during
the course o f another mental disorder (e.g. major 
depressive disorder, generalised anxiety disorder, a 
delirium).
•  The disturbance is not due to the direct
physiological effects o f a substance (e.g. drug 
abuse, medication) or a general medication 
condition.
• The sleep difficulty occurs despite adequate opportunity.
• At least one o f the following forms o f  daytime 
impairment related to the nighttime sleep difficulty is 
reported:
- Fatigue or malaise.
- Attention, concentration, or 
memory impairment.
- Adverse impact on school, 
work or social activities.
- Mood disturbance or 
irritability.
- Daytime sleepiness.
- Lack o f energy or 
motivation.
- Driving errors.
- Tension, headaches, or 
gastrointestinal symptoms.




Disorder o f somatisized tension 
and learned sleep-preventing 
association
Idiopathic Insomnia Paradoxical Insomnia




evidence o f any sleep 
disturbance.
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Table 2: ICSD-2 Diagnostic Criteria for Psvchophvsiological Insomnia and Idiopathic Insomnia*
Core Features for Psvchophvsiological Insomnia and Idiopathic Insomnia
• The patient’s symptoms meet the criteria for insomnia.
• The sleep disturbance is not better explained by another sleep disorder,
medical or neurological disorder, mental disorder, medication use or 
substance use disorder.
Core Features for 
Psvchophvsiological Insomnia
Core Features for 
Idiopathic Insomnia
The insomnia is present for at least one month.
The patient has evidence o f conditioned sleep difficulty and / 
or heightened arousal in bed as indicated by one or more of  
the following:
o Excessive focus on and heightened anxiety about 
sleep.
o  Difficulty falling asleep in bed at the desired
bedtime or during planned naps, but no difficulty 
falling sleep during other monotonous activities 
when not intending to sleep.
o Ability to sleep better away from home than at 
home.
o  Metal arousal in bed characterised either by 
intrusive thoughts or a perceived inability to 
volitionally cease sleep-preventing mental activity.
o Heightened somatic tension in bed reflected by a 
perceived inability to relax the body sufficiently to 
allow the onset o f sleep.
The course o f the disorder is chronic, as 
indicated by each o f  the following:
o  Onset during infancy or 
childhood 
o No identifiable precipitant or 
cause
o  Persistent course with no
periods o f sustained remission
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Chapter Three
Reflective Account Course 12 
(ABSRACD
Attached to Attachment
A reflective account o f my relationship with Attachment Theory and my 
development as a Trainee Clinical Psychologist.
(See part two for full account)
Address correspondence to: Laura Barrie, Section of Psychological Medicine, University of 
Glasgow, Division of Community Based Sciences, Academic Centre, Gartnavel Royal 
Hospital, 1055 Great Western Road, Glasgow G12 OXH.
E-mail: Laura.Barrie@gcc.scot.nhs.uk




My very first lecture on Attachment Theory (Bowlby, 1969) was a revelation in understanding 
psychological distress and human behaviour. However, only as a result of recent supervision 
and my current experience of clients with attachment disorders, have I reached an awareness 
of how Attachment Theory can effectively be utilised in an adult population. In the course of 
this essay I aim to reflect upon my development of applying Attachment Theory in my clinical 
practice. I will use established models of reflection and the concept of the Internal Supervisor 
(Casement, 1985) to describe significant learning experiences that have taken place which 
have ensured my progression from unawareness and being unsure of appropriate interventions, 
to a state of awareness and suitable application. As I reflect upon my relationship with 




Reflective Account Course 12 
(ABSRACT)
How can you help me i f  you don’t know who I  am ?
A Reflective Account o f a Trainee Clinical Psychologists’ struggle to deliver 
Evidence-Based Practice within a Culturally Sensitive Framework
(See part two for full account)
Address correspondence to: Laura Barrie, Section of Psychological Medicine, University of 
Glasgow, Division of Community Based Sciences, Academic Centre, Gartnavel Royal 
Hospital, 1055 Great Western Road, Glasgow, G12 OXH.
E-mail: Laura.Barrie@gcc.scot.nhs.uk




Delivering evidence-based practice and respecting culture and diversity are considered core 
competencies for Clinical Psychologists. In delivering psychological interventions, I have 
become aware of the tension often created when trying to deliver evidence-based practice in a 
culturally sensitive way. This is a reflective account of my professional struggle in trying to 
apply scientific rigour within a cultural framework.
Gibbs’s Reflective Cycle and Schon’s model of reflecting both in-action and on-action have 
enabled me to reflect in a thoughtful manner and to think innovatively about future practice. 
Whilst acknowledging that challenges continue to exist, there is a realisation that 
consideration of the clients’ culture is essential for reaching a shared understanding of 
psychological distress. Only then can the delivery of evidence-based practice be achieved.
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Appendix 1.1
Journal of Consulting and Clinical Psychology -  Notes for Contributors
Instructions to Authors
The Journal o f  Consulting and Clinical Psychology (JCCP) publishes original contributions on the 
following topics:
a. the development, validity, and use of techniques of diagnosis and treatment of disordered 
behavior
b. studies of a variety of populations that have clinical interest, including but not limited to 
medical patients, ethnic minorities, persons with serious mental illness, and community 
samples
c. studies that have a cross-cultural or demographic focus and are of interest for treating 
behavior disorders
d. studies of personality and of its assessment and development where these have a clear 
bearing on problems of clinical dysfunction and treatment
e. studies of gender, ethnicity, or sexual orientation that have a clear bearing on diagnosis, 
assessment, and treatment
f. studies of psychosocial aspects o f health behaviors
g. methodologically sound case studies pertinent to the preceding topics. Studies that focus on 
populations that fall anywhere within the lifespan are considered
JCCP welcomes submissions on treatment and prevention in all areas of clinical and clinical-health 
psychology and especially on topics that appeal to a broad clinical-scientist and practitioner audience. 
JCCP encourages the submission of theory-based interventions, studies that investigate mechanisms 
of change, and studies of the effectiveness of treatments in real-world settings.
Studies on the following topics will be considered if they have clear implications for clinical research 
and practice: epidemiology; use of psychological services; health care economics for behavioral 
disorders; theoretical papers; and critical analyses and meta-analyses of treatment approaches on 
topics of broad theoretical, methodological, or practical interest to the field of clinical psychology.
JCCP does not consider manuscripts dealing with the etiology or descriptive pathology of abnormal 
behavior (which are more appropriate for the Journal o f  Abnormal Psvcholoev). Similarly, the 
journal does not consider articles focusing primarily on assessment, measurement, and diagnostic 
procedures and concepts (which are more appropriate for Psychological Assessment). Editors reserve 
the right to determine the most appropriate location of a manuscript.
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Length and Style of Manuscripts
Full-length manuscripts should not exceed 35 pages total (including cover page, abstract, text, 
references, tables, and figures), with margins of at least 1 inch on all sides and a standard font (e.g., 
Times New Roman) of 12 points (no smaller). The entire paper (text, references, tables, etc.) must be 
double spaced.
Instructions on preparing tables, figures, references, metrics, and abstracts appear in the Publication 
Manual o f  the American Psychological Association 15th edition).
For papers that exceed 35 pages, authors must justify the extended length in their cover letter (e.g., 
reporting of multiple studies), and in no case should the paper exceed 45 pages total. Papers that do 
not conform to these guidelines may be returned without review.
The References section should immediatelv follow a page break.
Title of Manuscript
The title of a manuscript should be accurate, fully explanatory, and preferably no longer then 12 
words. The title should reflect the content and population studied (e.g., "treatment of generalized 
anxiety disorders in adults").
If the paper reports a randomized clinical trial (RCT), this should be indicated in the title, and the 
CONSORT criteria must be used for reporting purposes.
Abstract and Keywords
Manuscripts must be accompanied by an abstract containing 125-180 words. All abstracts must be 
typed on a separate page (p. 2 of the manuscript). Abstracts must contain a brief statement about each 
of the following:
• the purpose/objective;
• the research methods, including the number and type of participants;
• a summary of the key findings;
• a statement that reflects the overall conclusions/implications 
After the abstract, please supply up to five keywords or short phrases.
Discussion of Clinical Implications
Articles must include a discussion of the clinical implications of the study findings or analytic 
review. The Discussion section should contain a clear statement of the extent of clinical application 
of the current assessment, prevention, or treatment methods. The extent o f application to clinical 
practice may range from suggestions that the data are too preliminary to support widespread 
dissemination to descriptions of existing manuals available from the authors or archived materials 
that would allow full implementation at present.
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Appendix 1.2
Quality Measure for Systematic Review
Article Number:
Study Design (chose 1 only):
What was the study question:
Problem area:
* Total score:
Treatment / Adherence to Protocol
Has a clear rationale for the treatment been given and an adequate description o f  its content? 2, 1, 0 
Has the treatment duration and setting been reported? 2 , 1 , 0
Is there a treatment manual that describes the active components o f (all) treatment? 2,1,0, NA 
Is there evidence that therapists are adhering to treatment protocol? 2 , 1 , 0  
Have the therapists been appropriately trained in the relevant procedures? 2 , 1 , 0  
Is there evidence that the patients have actively engaged in the treatment? 2,1,0
Subscore: ______
Methodology
Was the study question sufficiently described? (2, 1,0)
Was the study design appropriate to answer the study question? 2, 1, 0 
Were both the inclusion and exclusion criteria specified? 2, 1, 0 
Is there a good description of the sample in the trial? 1, 0 
Were participants appropriate to the study question? 2 , 1 , 0  
Were control participants appropriate? 2, 1,0, N/A 
Was the study described as randomized? 2, 0
If participants were randomly selected, was the method o f random selection sufficiently well described? 2, 0, N/A 
Was the process o f randomisation robust? 2, 0, N/A 
Were investigators blind to intervention? 2, 0, NA 
Were participants blind to intervention group? 2, 0, NA
Was measurement bias accounted for by methods other than blinding (no difference between comparison groups in how assessment and 
outcome measures are ascertained / intention to treat analysis performed)? 2, 1,0,  NA  
Was there a sample size justification before the study? 1, 0, NA
Does the study use appropriate analysis (i.e. Intention to treat analysis) to address the research question and for which the conditions o f use
can be confirmed? 2, 1,0, NA
Were statistical tests stated? 2, 1, 0
Is there adequate reporting o f summary statistics? 2, 1, 0
Were exact p values or confidence intervals reported for each test? 2 , 1 , 0 ,  NA
Were pos-hoc power calculations or confidence intervals reported for statistically non-significant results? 1, 0, NA 
Were confounding variables accounted for by analysis? 2, 1, NA  
Were attrition o f participants and reasons for attrition recorded? 2, 1, 0
For those participants that completed the study, were the results completely reported? 2, 1,0, NA  
Do the findings support the conclusions? 2, 1, 0 
Subscore: ______
Assessment o f Psychological Distress
Has a valid measure o f psychological distress been used as an outcome measure? 2, 1, 0
Has a reliable measure of psychological distress been used as an outcome measure? 2, 1, 0
Has there been a measure o f any sustainable change between the treatment and control groups? 1, 0, N A
Subscore: ______
Assessment o f Quality o f Life
Has quality of life been measures using a standard Quality o f Life instrument?
Has there been a measure o f any sustainable change between the treatment and control groups? 1, 0, NA
Subscore: ______
*Total score = Treatment / Adherence to Protocol + Methodology 
(Do not give credit for items that are not explicitly stated).
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Appendix 1.3
Flowchart of Search Strategy for Systematic Literature Review
7 abstracts fitted inclusion criteria for review.
Correspondence via 
relevant authors and 
website. 1 article 
added to the review.
Total number of 
papers included in 
review: 8
Following removal of duplicates this resulted in 832 hits.
Full text articles reviewed. Reference lists checked 
for other relevant papers.
Behavior Therapy 
and Cognitive and 
Behavioural Practice 
hand searched for 
relevant papers. No 
articles added to the 
review.
Following removal of duplicates, this resulted in 229 hits from search strategy to be 
considered.
Abstracts reviewed to ensure that only ACT intervention studies would be reviewed. This resulted in 
67, of which 31 were not intervention studies.
Search terms employed:[acceptance and commitment therapy]or [ACT]or [Acceptance] or [Acceptance 
+ commitment]or [acceptance based approaches] or [Third Wave]
Further restriction of search 
[acceptance and commitment therapy] or[ACT] or [acceptance + commitment (title only)]or 
[acceptance based approaches].
Databases searched 
The Cochrane Library > November (wk 2) 2007 
MEDLINE > 1980 -  November 2007 
EMBASE > 1988 -  November (wk2) 2007 
CINAHL > 1982 - December (w kl) 2007 
PsycINFO > 1985 -  December (wkl) 2007
Study with less than 10 
participants.
Study included child or 
adolescent participants.
Study did not deliver ACT as 
a stand alone package.
29 articles excluded due to 
the following:













XI Blackledge, J., & Hayes, S. (2006). Using acceptance and 
commitment training in the support o f parents o f children diagnosed 
with autism.
Bond, F., & Bunce, D. (2000) Mediators o f change in emotion- 
focused and problem-focused worksite stress management 
interventions.
Dahl, J., Wilson, K.G., Nilsson A. (2004). Acceptance and 
commitment therapy and the treatment of persons at risk for long­
term disability resulting from stress and pain symptoms: A 
preliminary randomized trial.
Garcia, F., Villa, S., Cepeda, T., Cueto, G., & Montes, G. (2004). 
Effect o f hypnosis and Acceptance and Commitment Therapy (ACT) 
on physical performance in canoeists.
Gifford, E.V., Kohlenberg, B.S., Hayes, S. C., Antonuccio, D.O., 
Piasecki, M. M., Rasmussen-Hall, M. L., Palm, K. M., (2004). 
Acceptance-based treatment for smoking cessation.
Gutierrez, O., Luciano, C., & Fink, B. C. (2004). Comparison 
between an acceptance-based and a cognitive-control-based protocol 
for coping with pain.
Hayes, S. C., Bissett, R., Roget, N., Padilla, M., Kohlenberg, B. S., 
Fisher, G., et al. (2004). The impact o f acceptance and commitment 
training on stigmatizing attitudes and professional bumout of 
substance abuse counsellors.
Jimenez, R. (2006). Application o f Acceptance and Commitment 
Therapy (ACT) to improve chess-players performance. A case study.
Lillis, J. (2008). Acceptance and commitment therapy for the 
treatment o f obesity-related stigma and weight control.
Masuda, A., Hayes, S., Fletcher, L., Seignourel, P., Bunting, K., 
Herbst, S., Twohig, M., Lillis, J. (2007). Impact o f acceptance and 
commitment therapy versus education on stigma toward people with 
psychological disorders.
Zettle, R. (2003). Acceptance and commitment therapy (ACT) vs. 
systematic desensitization in the treatment of mathematics anxiety.
N <  10 XI Asmundson, G. & Hadjistavropolous, H. (2006). Acceptance and 
Commitment Therapy in the Rehabilitation o f a Girl with Chronic 
Idiopathic Pain: Are We Breaking New Ground?
Batten, S., Hayes, S. (2005). Acceptance and Commitment Therapy 
in the Treatment of Comorbid Substance Abuse and Post-Traumatic 
Stress Disorder: A Case Study.
Heffner, M., Eifert, G., Parker, B., Hernandez, D., Sperry, J. (2001) 
Valued directions: Acceptance and commitment therapy in the
treatment o f alcohol dependence.
Heffner, M., Sperry, J., Eifert, G., Detweiler, M. (2002) Acceptance 
and commitment therapy in the treatment o f an adolescent female 
with anorexia nervosa: A case example.
Magnusson, B., Olsson, G. (2005). Using acceptance and 
commitment therapy in the rehabilitation of an adolescent female 
with chronic pain: A case example.
Montesinos M., Francisco; H, Luciano S. (2001). Application of 
acceptance and commitment therapy in cancer patients.
Orsillo, M., & Batten, S. (2005). Acceptance and Commitment 
Therapy in the Treatment of Posttraumatic Stress Disorder.
Pankey, J., & Hayes, S. (2003). Acceptance and commitment 
therapy for psychosis.
Twohig, M, Hayes, S., Masuda, A. (2006). Increasing Willingness to 
Experience Obsessions: Acceptance and Commitment Therapy as a 
Treatment for Obsessive-Compulsive Disorder.
Twohig, M., & Woods, D. (2001). Habit Reversal as a treatment for 
chronic skin picking in typically developing adult male siblings.
Twohig, M., Hayes, S., Masuda, A. (2006). Preliminary 
investigation of acceptance and commitment therapy as a treatment 
for chronic skin picking
ACT not 




VII Gratz, K., & Gunderson, J. (2006). Preliminary data on an 
acceptance-based emotion regulation group intervention for 
deliberate self-harm among women with Borderline Personality 
Disorder.
Levitt, J., Brown, T., Orsillo, S., & Barlow, D. (2004). The effects of 
acceptance versus suppression of emotion on subjective and 
psychophysiological response to carbon dioxide challenge in 
patients with panic disorder.
Lundgren, T., & Dahl, J. (2005). Development and evaluation of an 
integrative health model in treatment o f epilepsy: A randomized 
controlled trial investigating the effects o f a short-term ACT 
intervention compared to attention control in South Africa.
McCracken, L., Vowles, K., & Eccleston, C. (2005). Acceptance- 
based treatment for persons with complex, long-standing chronic 
pain: A preliminary analysis o f treatment outcome in comparison to 
a waiting phase.
Woods, D., Wettemeck, C., & Flessner, C. (2006). A controlled 
evaluation of Acceptance and Commitment Therapy plus habit 
reversal for trichotillomania.
Zettle, R., & Hayes, S. (1986). Dysfunctional control by client 
verbal behavior: The context o f reason giving.
Zettle, R., & Rains, J. (1989). Group cognitive and contextual 
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Insomnia is a common sleep problem resulting in daytime impairment including fatigue, cognitive 
impairment and psychological difficulties. The second revision of the International Classification 
of Sleep Disorders (ICSD-2) classifies Primary Insomnia into three subcategories: idiopathic 
insomnia II (II), psychophysiological insomnia (PI) and paradoxical insomnia. Despite potential 
differences between subtypes, clinicians currently manage people with insomnia in the same way. 
The concept of acceptance could potentially be useful in managing patients with a II.
Aims
This study aims to identify a significant sample of adults with II, and examine if there are 
significant differences in the way they perceive, cope and manage their sleep difficulties in 
comparison with individuals that have acquired onset in adulthood and good sleepers. This study 
will look at current levels of acceptance within these groups, and explore the relationship between 
acceptance and quality of life factors. In addition, it will be interesting to explore if given the 
choice, individuals would prefer a treatment which encouraged acceptance of the condition.
Methods
This study will be a quasi-experimental between-groups design with three groups: good sleepers 
(GS), adults with II and adults with PI insomnia. This study will compare the beliefs, coping 
styles, treatment preference and level of acceptability and will examine the potential value for 
acceptance in predicating quality of life measures.
Applications
Despite differences in presentation, patients with insomnia are treated and managed the same way 





Insomnia continues to be a common sleep disturbance in the general population. It is 
characterised by repeated failure to initiate, maintain or achieve quality sleep, resulting in 
daytime impairment including fatigue, cognitive impairment and psychological difficulties 
(International Classification of Sleep Disorders-2, 2005). Epidemiological studies of 
insomnia vary according to definition. The National Institute of Clinical Excellence 
reported that between eight to thirty-eight percent o f adults experience insomnia (NICE
2004) meanwhile Ohayon (2002) reported more conservative estimates o f six percent 
(Ohayon, 2002).
The study o f insomnia has become an active research area and recent developments have 
shown that psychological factors are critical to the development, maintenance, and 
treatment o f insomnia (Espie, Inglis, Tessier, and Harvey, 2001; Wang, Wang and Tsai,
2005). Despite the activity going on in this area, controversy still surrounds the utility of 
insomnia subtypes. Sleep specialists argue that consideration of insomnia subtypes is 
crucial in terms of understanding the etiology of insomnia, for designing effective 
treatment and enhancing communication (Buysse, Reynolds, Hauri, Roth, Stepanski, 
Thorpy, Bixler, Kales, Manfredi, Vgontzas, Stapf, Houck and Kupfer 1994, Edinger and 
Krystal 2003).
The American Academy of Sleep Medicine conducted a review of the literature on studies 
evaluating chronic insomnia. They advised that clinicians should be familiar with the 
major diagnostic groups (Sateia, Doghramji, Hauri and Morin 2000). Although experts in 
the field have criticized the inclusion of distinct categories which appear to be a result of 
clinical as opposed to empirical findings. Sleep experts argue that clarification in terms of
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sub categories o f insomnia is fundamental in enhancing communication, understanding the 
aetiology of insomnia and in providing effective management.
II is diagnosed when an individual meets the following criteria: (a) the patient’s symptoms 
meet the criteria for insomnia, (b) the course of the disorder is chronic, as indicated by 
each of the following (i) onset during infancy or childhood (ii) no identifiable precipitant 
o f cause (iii) persistent course with no periods o f sustained remission, (c) the sleep 
disturbance is not better explained by another sleep disorder, medical or neurological 
disorder, mental disorder, medication use, or substance use disorder (ICSD-2 2005). The 
nature o f II has proved to be both controversial and conceptually a difficult area to define 
and research. Main reasons for this include a lack o f validation studies and issues with 
definition.
A literature review by the Working group for DSM III-R concluded that although the term 
had clinical utility, there was limited empirical support and did not include it in DSM III 
(Reynolds, Kupfer, Buysse, Coble and Yeager 1991). Currently Edinger and colleagues 
are conducting a major insomnia diagnostic trial to investigate the reliability and validity 
o f insomnia diagnoses in the DSM-IV and ICSD-2. Although this is not due to be 
published until 2008 it will be interesting to see if  further consideration is given to II.
Whereas it is often suggested that PI can develop after a stressful event, there has been a 
lack of explanation to account for the development o f II. Some studies have found 
evidence o f a weak circadian rhythm (Smits et al., 2001), and physiological differences 
between good and poor sleepers prior to sleep, during sleep and during the day. This 
includes increased rectal temperature, heart rate, basal skin resistance, and phasic 
vasoconstrictions thirty minutes before sleep. Poor sleepers also show more beta and less
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alpha frequencies in their sleep, and have increased secretion of corticosteroids and 
adrenaline compared to good sleepers (Bonnet and Arand, 1997). Therefore it may be that 
answers may lie in an overactive awakening system, or an under active sleep system.
An interesting review by Bonnet and Arand (1997) supported the notion that chronic 
insomnia patients mainly suffer from a physiological disorder o f hyperarousal. Nofzinger, 
Buysse, Germain, Price, Miewald and Kupfer (2004) reported on functional neuroimaging 
performed on healthy patients and patients with II. They found that an inability to fall 
asleep might be related to a failure in the arousal mechanisms to decline in activity from 
wakening to sleep states. Therefore, individuals with II may have a physiological 
vulnerability, and of course, the unrelenting nature of the disorder would result in coping 
styles that maintain the insomnia. It is important to note that although most patients 
experiencing insomnia would present with higher levels of arousabilty, Edinger et al., 
(1988) provided evidence that adults with II would have higher levels. Therefore 
arousabilty may be a predisposing and maintaining factor in II, whilst having more of a 
precipitating and maintaining role in insomnia acquired in adulthood.
Chronic health problems and illness perception
The literature on chronic pain may be helpful in relation to II. Pain similar to II can be 
frequent or occasional, and be mild to severe. Chronic pain, like II, is associated with 
being unresponsive to treatment and being poorly understood. Although there is an 
emphasis on physiological factors, psychological factors appear to be critical in reducing 
ongoing difficulties. Research looking at patient perceptions of what helps in dealing with 
chronic pain, emphasise the following: empathy, validation, humour and most importantly 
‘when the clinician realizes that the patient needs healing, not treatment’ (Imes, Clance, 
Gailis and Atkeson, 2002).
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Clinicians are restricted by their training and in cases such as chronic insomnia, it appears 
that there is a clear protocol for working with adults with insomnia regardless of 
chronicity, severity and patient perceptions. In working with patients diagnosed with a 
chronic illness, clinicians are encouraged to be flexible in their approach to therapy and 
consider alterative approaches such as existential therapy (Imes et al, 2002) and 
mindfulness-based approaches (Brown, 2002). Concepts derived from mindfulness-based 
approaches are now considered to be core elements of current cognitive therapy (Teasdale, 
1999; Kabat-Zin, 1990).
Rainer (2002), states that psychologists play an important role in helping patients with 
chronic health conditions. Cognitive behaviour therapy should therefore move towards 
encouraging the patient to accept the condition, and help the patient to restructure 
unhelpful thoughts that reduce quality of life factors. For example, Rainer states that when 
patients view that they are helpless, and make statements about being unable to do 
anything due to feeling lethargic; cognitive therapy should look at encouraging the patient 
to increase energy levels and identify dysfunctional thoughts (Arena, 2002). Most 
importantly, studies provide support that the role of acceptance in chronic health 
conditions has important implications for quality of life factors and psychological well­
being (Van Damme, Crombez, Van Houdenhove, Mariman, and Walter, 2006; Giza- 
Zwierzchowska, 2005; McCracken and Eccleston, 2005; McCracken, Vowles, Eccleston, 
2005; Nicholas and Asghari, 2005; Viane, Crombez, Eccleston, Poppe, Devulder, Van 
Houdenhove and De Corte, 2003)
Role o f  treatment preference and acceptance in chronic conditions
Treatment preference and acceptability o f treatment is vastly overlooked in a range of
clinical disorders. Therefore, although a treatment may be effective, patients have to accept
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the treatment as suitable for it to be clinically useful (Morin 2006, Morin, Gaulier, Barry 
and Kowatch, 1992). Using the Treatment Acceptability Scale (Morin. Gaulier, Barry, 
and Kowatch, 1992), Gagne and Morin (2001) explored patients’ preference when given 
the choice of behavioural therapy and pharmacotherapy for treating insomnia within an 
older adult population. They found that that the majority of patients opted for behavioural 
therapy and that acceptability o f treatment related to better outcomes. Due to the lack of 
studies looking at differing treatments for II, and given the unrelenting nature of the 
disorder and suggestion of being less responsive to behavioural treatment, it seems 
reasonable to suggest that psychological therapy should be directed towards helping these 
patients accept their condition and cope with their chronic condition.
Evidence from research on illness beliefs using the Illness Perception Questionnaire and 
revised version (Weinman, Petrie, Moss-Morris, and Home 1996; Moss-Morris, Weinman, 
Petrie, Home, Cameron and Buick, 2002) have shown that beliefs and individual 
perceptions of illness play a role in explaining factors such as adherence, coping and 
psychological outcomes (Moss-Morris et al 2002). It will therefore be important to look at 
how individuals with a II differ from adults with PI.
The role o f  acceptance
The role o f acceptance has gradually become an important psychological concept in a 
range o f chronic and unrelenting medical and psychological disorders: Borderline 
Personality Disorder (Linehan 1993), Psychosis (Bach and Hayes 2002) Pain (Hayes 1999, 
McCracken and Eccleston 2005, McCracken et al 2005), Chronic Fatigue Syndrome (Van 
Damme et al 2006), HIV and AIDS (Giza-Zwierzchowska 2005). It seems that acceptance 
is favoured in situations, which are out with the individual’s control. It is felt that
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providing individuals with ways of controlling maladaptive thoughts and behaviours is 
detrimental, as the situation is uncontrollable.
Acceptance can be viewed as an alternative to trying to control the disorder, and 
acknowledging that the condition may not change. It therefore shifts the individual to 
move away from focusing on disorder specific aspects o f life, to non-disorder aspects of 
life. Most notably, acceptance has been receiving attention in the pain literature, and can be 
useful given its similarity to insomnia to help think about the role of acceptance in adults 
with II. McCracken and Eccleston (2003) define acceptance as ‘halting the dominant 
search for a definite solution of physical complaint and as a reorientation of attention 
towards positive everyday activities and other aspects of life’.
McCracken and his colleagues incorporated aspects Acceptance and Commitment 
Therapy, first pioneered by Hayes (1999) when working with patients with chronic pain. 
Patients with chronic pain view their disorder as distressing, adapt to pain by living with 
inflexible behaviour patterns, and associated thoughts, which have been shown to affect 
quality of life issues. For example a patient experiencing chronic pain, may believe that if  
they arrange an outing, they will be unlikely to go and will therefore restrict themselves to 
a lifetime o f limited activity.
Research shows that for patients willing to have pain but continue to engage in activities 
regardless o f pain achieve healthier life functioning in quality of life measures. Although 
McCracken (2003) does not claim that acceptance-based approaches will reduce patients 
pain, it has been shown to have significant increases in social, physical and psychological 
functioning, and have higher effect than traditional coping strategies such as ‘distraction’ 
and ‘distancing’ (McCracken et al, McCracken and Eccleston 2005, Viane et al 2003)
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Therefore, if  one were to draw parallels with insomnia, we would not be looking for a 
reduction in severity of symptoms, but in being able to accept insomnia as lifelong and 
reduce energy and distress that is consumed by trying to control insomnia.
Lundh and colleagues are currently researching the role of acceptance and mindfulness in 
the treatment o f insomnia (Lundh, 2005). Lundh specifies that clinicians should explore 
patients current control strategies and when applicable, explore the futile nature o f them. 
Patients should be encouraged to adopt the attitude that thoughts and behaviours associated 
with insomnia should not be evaluated as something to get rid of. Most importantly, 
encouraging patients to realize that insomnia is out with their control and that this must be 
accepted. It will therefore be interesting to see if  the level o f acceptance differs between 
adults with II, and adults with II or if  level o f acceptance will vary between individuals 
regardless o f onset.
Coping and insomnia
In trying to determine which patients may benefit from an acceptance-based approach, the 
role of individual coping styles may be interesting. There have been numerous studies 
looking at coping styles across populations: cancer (Arraras, Wright, Jusue, Tejedor and 
Calvo, 2002), diabetes (Nadeau, 1995), HIV (Tumer-Cobb, Gore-Felton, Marouf, 
Koopman, Kim, Israelski, and Spiegel (2005). Health psychologists have provided 
evidence to show that coping styles can potentially affect acceptance, prognosis and 
quality o f life measures.
The following coping styles have been identified in the literature: emotion focused, 
problem solving, confrontative, distancing, self-controlling, seeking social support, 
accepting responsibility, escape avoidance, repressive, denial and positive reappraisal.
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Previous research has identified that adults with II are more likely to report denial and 
repressive coping styles (Hauri, 1983).
There has been a recent interest in coping styles o f patients with insomnia, and even more 
recently the issue o f different types o f coping styles within acute and chronic insomniacs. 
Ellis and Cropley (2002) examined coping style and attributions between one-hundred and 
forty-six acute insomniacs, and one-hundred and sixty-two chronic insomniacs and three- 
hundred and four good sleepers. Their study showed that a ‘distraction’ coping style acted 
as a buffer against chronic insomnia. They also explored attitudes to sleep and sleep 
disrupting behaviours, which can lead to the progression of chronic insomnia in vulnerable 
patients. Therefore, coping style was identified as a factor for developing chronic 
insomnia. The literature on sleep and coping indicates that ways of coping may be 
influenced by how individuals perceive this problem and may influence treatment 
acceptability
In considering treatment options for patients with childhood insomnia, it is important to 
appreciate how these patients may differ from individuals that present with PI. Clearly 
further work on II is required in terms of how they perceive their insomnia, coping styles, 
and expectations of treatment. Given that patients acceptance of treatment is a powerful 
predictor o f adherence and treatment effectiveness, clinicians must be able to offer patients 
choice in this decision making process. Finally, given the nature o f II, it will be useful to 
explore if encouraging patients to accept their insomnia and focus on improving quality of 
life issues would prove to be a popular treatment option.
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Aims and Hypothesis 
Aims
Although this study is not designed to be a validation study of II, it aims to identify a 
significant sample of adults with II, and examine if  they differ in the way they perceive and 
view their sleep difficulties when compared to insomniacs with PI and good sleepers. The 
study will also examine the relation between beliefs and perceptions of insomnia and 
treatment preference. Finally, this study will explore how these factors relate to treatment 
choice, acceptability and quality of life issues.
It was expected that participants with II would view their sleep difficulties as more chronic 
and permanent, and would report less control over their difficulties than participants with 
PI and good sleepers, and participants with II would be more likely to report ‘denial’ and 
‘repressive’ coping styles in comparison to participants with PI and good sleepers. It was 
also expected that participants who viewed their insomnia as chronic and uncontrollable 
would be more likely to opt for treatment that encourages acceptance o f insomnia. Finally, 




Beck’s Depression Inventory (BDI)
The BDI is a 21-item questionnaire used to measure self-reported depressive symptoms. It 
has been widely used to measure depressive symptoms and has been shown to be sensitive 
and moderately specific in identifying depressive disorders. This measure will therefore be 
able to identify and exclude participants with severe depressive symptoms.
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Beck’s Anxiety Inventory (BAI)
The BAI is similar to BDI. It is a 21-item questionnaire that measures the severity o f 
anxiety in adults. This measure will therefore be able to identify and exclude participants 
with high levels of anxiety.
Pittsburgh Sleep Quality Index (PSQI)
The Pittsburgh Sleep Quality Index PSQI has been selected as it is the most efficient 
measure o f sleep quality and patterns o f sleep This score has been shown to discriminate 
between good and poor sleepers (diagnostic sensitivity o f 89.6% and specificity o f 86.5%).
Insomnia Severity Index (ISI)
The ISI has been reported to be a reliable and valid instrument for reporting perceived 
insomnia severity. The ISI is a self-report measure, which asks the rater to state how severe 
their insomnia is, how much they feel it, the impact it has on their life and how distressed 
they are by it. Adequate internal consistency of this measure has been reported.
Dysfunctional Beliefs and Attitudes about Sleep Scale (DBAS 16)
Beliefs and attitudes will be measured using the Dysfunctional Beliefs and attitude about 
Sleep Scale. It contains 16 statements with an analogue scale for the responder to state 
whether they strongly agree or strongly disagree. This Questionnaire is used to measure 
the individual’s beliefs about the consequences of their insomnia, sleep expectations and 
level o f worry and helplessness associated with sleep.
Sleep diary
Daily sleep diaries will be completed over a 1 -week period. This will provide an estimate 
o f sleep efficiency and sleep quality. They will also be used to validate group allocation.
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Structured interview
The format of the SIS is a semi-structured questionnaire with specific questions on 
physical and mental health, medication and alcohol use, and symptoms of other sleep 
disorders. This requires a degree o f clinical judgement and provides an alternative to self- 
report data.
Assessment measures:
Illness Perception Questionnaire-Revised (IPQ-R)
This will measure differences between people in terms of the control they have and how 
they cope. This measure provides adequate measures of structural validity, internal 
reliability, test-retest reliability, discriminate validity and predictive validity. This tool can 
be adapted to suit particular populations and should therefore yield valid scores on 
participants with insomnia.
The Brief COPE questionnaire
The Brief Cope Questionnaire has been used in a number of health relevant studies and 
explores the following: active coping, planning, positive refraining, acceptance, humour, 
religion, using emotional support, using instrumental support, self-distraction, denial, 
venting, substance use, behavioural disengagement, and self-blame. This 28-item version 
of Cope is reported to have psychometric properties consistent with the original 60-item 
version.
Treatment Acceptability Scale -  adapted (TAC)
The Treatment Acceptability Scale provides patients with two treatment methods 
(behavioural treatment method and pharmacological treatment method). Participants are
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then asked if they would consider either o f the methods as potential treatment options, and 
rate the acceptance, willingness, effectiveness and suitability of each treatment. This 
current measure will be adapted to include a third option ‘acceptability’.
Illness Cognition Questionnaire (ICQ)
Validation studies on the ICQ-acceptance subscale have shown that it is a reliable and 
valid assessment of acceptance of patients with a chronic a disease
The Short Form 36 (SF-36) Health Survey Questionnaire
The SF36 is a quality o f life measure, covering the following domains considered to 
important in quality of life issues: physical functioning, role limitations due to physical 
health, bodily pain, social functioning, general mental health, role limitations due to 
emotional health, vitality, general health perceptions.
Design
This study will be a quasi-experimental between-groups design with three groups:
Adults with II, Adults with PI and good sleepers (GS). In order for there to be a clear 
distinction between groups, the II group will be required to have developed insomnia by 
aged ten and PI group on or following their eighteenth birthday. Group will be the main 
independent variable. Scores obtained from the Illness Perception Questionnaire-R, the 
Brief COPE, Treatment Acceptability Scale and Short Form 36 will be dependant 
variables. Demographic and additional sleep data for participants will be collated and 




Participants will be age 18 years and over and will have responded to an advertisement 
looking for good sleepers (GS), adults with II and adults with PI.
Inclusion and exclusion criteria
Both the II group and the PI group will meet criteria for insomnia as defined by ICSD-2 
diagnostic criteria for insomnia. The NS group will meet criteria in accordance with 
research diagnostic criteria for good sleepers (Edinger, 2004). Data obtained from sleep 
diaries will support group allocation.
Participants will be excluded from the study if a) there is presence o f other sleep disorders 
such as narcolepsy, sleep apnea, restless legs syndrome, circadian sleep disorders or 
parasomnias b) participants show evidence of mood disorders or substance abuse c) if 
participant was receiving psychotherapy d) experiencing a somatic disorder that is 
influencing sleep. This information will be obtained from screening measures and clinical 
interview.
Firstly, participants will be invited to contact the researcher by e-mail / telephone if they 
wish to participate in the study. The researcher will then provide further information 
regarding the study and a Participants Information Sheet will be dispatched. If participants 
are still interested in participating, they will be invited to meet the researcher to complete a 
set o f questionnaires and participate in a brief semi-structured interview. Participants will 
also be asked to complete a 7-day sleep diary prior to meeting. Individuals not meeting 
the criteria will be fully debriefed regarding the aims and objectives o f the study and will 
be offered a copy of ‘The Good Sleep Guide’ a leaflet providing advice on improving
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sleep hygiene prepared by professor Colin Espie and recommended by the British Sleep 
Society.
Recruitment Procedures
Participants will be recruited via media recruitment. This will include posters 
advertisements and online recruitment via sleep forums. Previous sleep studies have 
yielded large sample using this method of recruitment.
Research procedures
Following initial telephone procedure and allocation, participants will be invited to the 
University of Glasgow Sleep Centre at the Sackler Institute of Psychobiological Research, 
to meet with the researcher. Participants will be sent a sleep diary that will be completed 
for a 1-week period. Participants will be given a brief written summary o f the aims and 
objectives of the study and will complete a consent form if  they wish to participate and will 
be advised that they can opt out of the study at any time and encouraged to ask questions. 
They will then be asked to complete a series of questionnaires. Prior to participants 
departing, they will be fully debriefed about the hypothesis behind the study and will be 
asked if they wish to receive feedback regarding the findings of the study. Participants 
complaining of poor sleep will be provided with a copy of ‘The Good Sleep Guide’ Espie. 
Data will then be coded and analyzed using the Statistical Package for the Social Sciences 
(SPSS).
Justification of Sample Size
Taking pervious studies into account, it was calculated that the present study would require 
thirty participants in each group to detect significant differences between groups if  they
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existed. According to Cohen (1992), this size of sample size should typically produce a 
large effect size on a t-test and ANOVA.
Settings and Equipment
Access to e-mail and telephone will be required for recruitment purposes. Glasgow 
University and the Sleep Research Laboratory at the Sackler Institute will provide suitable 
rooms for conducting interviews with participants and for participants to complete 
questionnaires.
Data Analysis
Demographic data will initially be analyzed to check if groups differ in terms of 
demographic variables, and severity. Mean scores, standard deviations, internal 
consistency will be reported. In the event that there are between group differences the 
relationship between the variable and the outcome measures will then be examined. If this 
relationship is found to be significant then it will be considered as a covariate in analysis. 
All data will be checked to ensure suitability for parametric testing. One-way ANOVA 
will be used to see if  there are significant differences between groups in terms of illness 
perception, and insomnia related thoughts and treatment preference. An ANOVA will be 
performed to explore treatment preference. A correlation analysis will explore the relation 
between quality of life and level of acceptance.
Health and Safety Issues 
Researcher Safety Issues
The study will adhere to the following procedures to ensure that there are no risks to the 
researcher in conducting this study. Firstly, an email account will be set up for the sole
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purpose of recruitment, ensuring that participants do not have access to personal 
information about the researcher. The researcher will meet participants in a secure 
building, and the researcher will ensure that this will be at a time when colleagues are 
present.
Participant Safety Issues
Participant will be fully briefed on study procedures prior to consent being obtained. 
Participants will be advised that interviews will take place during the day in a secure and 
occupied building. Following completions of the study, all identifiable data will be 
destroyed. For participants identified with insomnia, a copy of ‘The Good Sleep Guide’ 
will be provided.
Ethical Issues





Ethical approval will be sought: September 2007
Recruitment: November 2008 - May 2008
Write up: June 2008 -  August 2008
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Practical Applications
Despite differences in presentation, patients with insomnia are treated and managed the 
same way by clinicians. This study will consider how subtypes o f insomnia may differ, 
and how this may affect treatment effectiveness.
Ethical and Management Approval Submissions
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Amendments to Major Research Proposal
The following amendment to the proposal was made following ethical approval:
Title of Major Research Project
Removed;
Title: Does the concept of acceptance have a role to play in managing Childhood Onset 
Insomnia? A group comparison of beliefs, coping styles and treatment preferences in 
Childhood Onset Insomnia, Adult Onset Insomnia and Good Sleepers.
Replaced with;
Title: Does ‘acceptance’ have a role to play in managing Idiopathic Insomnia? A group 
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The Editor may invite editorials and commentaries. The Journal will not consider unsolicited 
editorials or commentaries. Editorials should be approximately 800-1000 words and contain no 
more than 16 references. The title for an editorial should not exceed 85 characters.
Fast-track Short Papers
These should be approximately 2000 words in length, with a maximum of four figures or tables. 
Fast-track papers are rapidly reviewed and published.
Regular Research Papers
These are of a more usual length (3000-5000 words), and will preferably be oriented towards 
basic clinical and non-clinical findings.
Review Papers
These are intended to be well argued, preferably controversial reviews of topical subjects which, 
it is hoped, will generate debate.
Letters to the Editor
The Editor welcomes succinct correspondence relating to articles published in the journal, and of 
an academic and interesting nature.
Title Page
This should contain a concise title o f the article, a shortened version (no more than 50 characters 
including spaces) for the running head, names of the authors, their affiliations, and the full postal 
and e-mail address, fax and telephone number of an author to whom
correspondence can be addressed.
Conflict of interests - disclosure of any personal o f financial support and author involvement 
with organization(s) with financial interest in the subject matter of the paper, or any actual or 
potential conflict o f interest-and if  no conflict exist, a statement must be included for each 
author.
Sum m ary
This should be on a separate page, and less than 250 words. It should be followed by up to six key 
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M ain Text
This should start on a separate page, and include an introduction, methods, results and 
discussion. The suggested points of insertion of figures and tables, etc., should be indicated. 
Authors should avoid abbreviations (except for those commonly understood), long sentences, 
and many juxtaposed numbers in sentences.
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Illustrations
These should be referred to in the text as figures using Arabic numbers, e.g. Fig. 1, Fig. 2, etc., in 
order of appearance. Each figure should be labelled with its appropriate number.
In the full-text online edition o f the journal, figure legends m aybe truncated in abbreviated links to 
the full screen version. Therefore, the first 100 characters o f any legend should inform the reader of 
key aspects of the figure.
Please save vector graphics (e.g. line artwork) in Encapsulated PostScript Format (EPS), and bitmap 
files (e.g. half-tones) in Tagged Image File Format (TIFF). Ideally, vector graphics that have been 
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It is the policy o f the journal for authors to pay the full cost for the reproduction o f their colour 
artwork. Therefore, please note that if  there is colour artwork in your manuscript when it is accepted 
for publication, Blackwell Publishing require you to complete and return a colour work agreement 
form before your paper can be published. This form can be downloaded on-line at:
http://www.blackwellpublishing.com/pdf/SN Sub2000 X CoW .pdf
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Appendix 2.4
Ethical Approval letters for Major Research Proposal / Project.
Research Ethics 
R&D Directorate 
Gartnavel Royal Hospital 
1055 Great Western Road 
Glasgow G12 OXH 
www.nhsggc.org.uk
Date 11 September 2007
M s Laura B arrie Your Ref
Trainee Clinical Psychologist 
University of Glasgow 
Department of Psychological Medicine 
Gartnavel Royal Hospital 
1055 Great Western Road 
G12 0XH
Dear Ms Barrie
Full title of study: Does the concept of acceptance have a role to play in managing
Childhood Onset Insomnia? A group comparison of beliefs,
coping styles and treatment preferences in Childhood Onset 
Insomnia, Adult Onset Insomnia and Good Sleepers.
REC reference number: 07/S0701/85
The Research Ethics Committee reviewed the above application at the meeting held on 06 
September 2007. Thank you for attending to discuss the study.
Ethical opinion
Members of the Committee present gave a favourable ethical opinion of the above research on the 
basis described in the application form, protocol and supporting documentation subject to the 
following being confirmed to the Committee Co-ordinator as soon as possible.
• Question A44 - data to be retained for 5 years and not 10 years as shown in application.
• Question A68 - The Researcher is required to inform the participant's GP should any distress 
arise. If scores indicate a clinical psychiatric disorder then the GP should be advised by the 
Researcher.
Ethical review of research sites
The favourable opinion applies to the research sites listed on the attached form.
Conditions of approval
The favourable opinion is given provided that you comply with the conditions set out in the 
attached document. You are advised to study the conditions carefully.
Approved documents
Our R ef




The documents reviewed and approved at the meeting were:
Document Version Date
Application 17 August 2007
Investigator CV Ms Laura 
Barrie
17 August 2007
Protocol Version 1 09 August 2007
Covering Letter
Interview Schedules/Topic Guides Version 1 17 August 2007
Questionnaire: Initial Contact Version 1 17 August 2007
Advertisement Version 1 17 August 2007
Participant Information Sheet Version 1 17 August 2007
Participant Consent Form Version 1 17 August 2007
: Supervisor's CV Prof Colin 
Espie
Treatment Acceptability Scale Version 1 17 August 2007
:Sleep Diary Version 1 17 August 2007
R&D approval
The study should not commence at any NHS site until the local Principal Investigator has obtained 
final approval from the R&D office for the relevant NHS care organisation.
Membership of the Committee
The members of the Ethics Committee who were present at the meeting are listed on the attached 
sheet.
Statement of compliance
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees (July 2001) and complies fully with the Standard Operating Procedures for 
Research Ethics Committees in the UK.
07/S0701/85__________________Please quote this number on all correspondence
With the Committee’s best wishes for the success of this project 
Yours sincerely
Liz Jamieson
Research Ethics Committee Co-ordinator on behalf of Dr Paul Fleming, Chair
17 th January 2008
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Ms L Barrie
Trainee Clinical Psychologist 
University of Glasgow 
Section of Psychological Medicine 
Gartnavel Royal Hospital 
1055 Great Western Road 
G12 0XH
Dear Ms Barrie
ETHICS COMMITTEE MINUTES -  10™ JANUARY 2008
I append for your information the following minute extract(s) from the minutes of the above 
meeting:
677 REQUEST TO RECRUIT PARTICIPANT AT STRATHCLYDE UNIVERSITY
The Committee considered a request from a researcher employed by Greater Glasgow and 
Clyde NHS who had sought permission to recruit participants at the University. It was 
noted that this investigation had been approved by an NHS Research Ethics Committee and 
had R&D management approval from the NHS. The Committee a g reed  that the researcher 
be permitted to recruit potential participants at the University of Strathclyde.
On behalf of the Committee I wish you every success with your project.
Yours sincerely
Mrs Gwen McArthur 
Head of Court Office
cc. Ms Z Wilson, Finance Office
Ms L McKean, Contracts Manager, Research & Innovation
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Ms Laura Barrie 
Psychological Medicine 
Academ ic Centre 
Gartnavel Royal Hospital 
1055 Great W estern Road 
G lasgow G12 OXH
18 October 2008
Dear Ms Barrie
Medical Faculty Ethics Committee
Project Title: Does the concept of 'acceptance' have a role to play in managing
Childhood Onset Insomnia? A group comparison of 'beliefs', 'coping 
styles' and 'treatment preference' in Childhood Onset Insomnia, Adult 
Onset Insomnia and Good Sleepers.
Project No.: FM03107
The Faculty Ethics Committee has reviewed your application and has agreed that
there is no objection on ethical grounds to the proposed study. They are happy
therefore to approve the project, subject to the following conditions:
• The research should be carried out only on the sites, and/or with the groups defined in 
the application.
• Any proposed changes in the protocol should be submitted for reassessm ent, except 
when it is necessary to change the protocol to eliminate hazard to the subjects or 
where the change involves only the administrative asp ects of the project. The Ethics 
Committee should be informed of any such changes.
• If the study does not start within three years of the date of this letter, the project should 
be resubmitted.
• You should submit a short end of study report to the Ethics Committee within 3 months 
of completion.
Yours sincerely




Recruitment Poster for Major Research





Do you have problems 
sleeping?
We are conducting studies which may be of interest to:
• adults with insomnia
• over-65s with insomnia
• adults with both depression and insomnia
• adults who have never slept well even as children
• adults with restless leg movements at night
• children with insomnia
Please telephone us at the Southern 
General Hospital on 07788943028
Headed paper
Appendix 2.6
Participant Information Sheet for Major Research Project
Adult Onset Insomnia and Childhood Onset Insomnia
Researcher: Laura Barrie, Trainee Clinical Psychologist, Section of Psychological Medicine, University
of Glasgow
You are being invited to take part in a research study. Before you decide it is important for 
you to understand why the research is being done and what it will involve. Please take 
time to read the following information carefully and discuss it with others if  you wish.
Ask if there is anything that is not clear or if  you would like more information. Take time 
to decide whether or not you wish to take part.
What is the purpose of the study?
Sleep difficulties are a common problem. At least one in ten adults has a problem getting 
to sleep or staying asleep. Adults can develop insomnia in childhood or adulthood, and as 
a result are likely to differ in the way they perceive and cope with their insomnia. In 
addition, treatment expectations and treatment preference may differ. Despite differences 
in presentation, patients with insomnia are treated and managed the same way by 
clinicians. It is hoped that the findings from this study will contribute to more effective 
treatments for sleep problems being developed in the future.
Why have I been chosen?
You have been given this information sheet because you have either indicated that you are 
a good sleeper or have been having sleep problems. All together, around 90 people will be 
studied in this project.
Do I have to take part?
It is up to you to decide whether or not to take part. If you do decide to take part, you will
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be given this information sheet to keep and be asked to sign a consent form. If you decide 
to take part you are still free to withdraw at any :ime, and without giving a reason, and any 
data collected from you will be destroyed.
What will happen to me if I take part?
If you decide to take part, you will be asked to complete a sleep diary for seven days. You 
will then be asked to take part in a short interview about your experiences o f sleep and 
complete a set of questionnaires relating to sleep. These questionnaires will relate to sleep 
quality, sleep related beliefs, coping mechanisms, treatment preference and acceptance of 
your sleep difficulties. There will also be some questions relating to your mental health and 
drug use.
The interview should last no longer than one hour, and will be held at University of Glasgow 
Sleep Research Laboratory at the Sackler Institute of Psychobiological Research
Will my taking part in this study be kept confidential?
All information, which is collected, about you during the course of the research will be kept 
strictly confidential. Any information about you, which leaves the hospital, will have your 
name and address removed so that you cannot be recognised from it.
What will happen to the results of the research study?
It is intended that they will be used as part of the principal researcher’s Doctorate in Clinical 
Psychology, and will also be submitted for publication in a scientific journal. If published, 
you will be able to obtain a copy of this from the researcher. You will not be identified in 
any publication.
Is there someone I can contact to seek independent advice about participating in this 
study?
Participants can contact Brian Rae - Research Manager at Greater Glasgow and Clyde NHS 
Research & Development office. Tel: 0141 232 9523
Contact for Further Information




Consent Form for Major Research Project
Headed Paper
Consent form
Title of project: Does the concept of ‘acceptance’ have a role to play in managing Childhood 
Onset Insomnia? A group comparison of ‘beliefs’ ‘coping style’ and ‘treatment preference’ in 
Childhood Onset Insomnia, Adult Onset Insomnia and Good Sleepers.
‘Differences between Adult Onset Insomnia and Childhood Onset Insomnia’
Name of Researcher: Ms Laura Barrie 
Please initial box
I confirm that I have read and understand the Participant Information Sheet for the above study, 
and have had sufficient opportunity to ask questions.
I understand that the participation is voluntary and that I am free to withdraw at any time, without 
giving a reason, and that all data relating to my participation will be destroyed.









Questionnaires for Major Research Project
1. Insomnia Perception Questionnaire-Revised.
2. Insomnia Cognition Questionnaire.
3. Brief Cope.
4. Treatment Acceptability Scale.
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N H SUNIVERSITY 
«/
GLASGOW G r e a te r  G l a s g o w  
a n d  C ly d e
Illness Perception Questionnaire
Your views about your insomnia
Listed below are a number of symptoms that you may or may not have experienced since 
your insomnia. Please indicate by circling Yes or No, whether you have experienced any of 
these symptoms since your insomnia, and whether you believe that these symptoms are 
related to your insomnia.
I have experienced this This symptom is related to 
Symptom since my insomnia my insomnia
P ain Y e s No Y e s No
S o r e  T hroat Y e s N o Y e s No
N a u s e a Y e s No Y e s No
B r e a th le ssn e ss Y es No Y es No
W eight L oss Y es No Y es No
Fatigue Y es No Yes No
Stiff Jo in ts Y es No Y es No
Sore E yes Y es No Y es No
W h eez in ess Y es No Y es No
U pset Stom ach Y es No Y es No
S leep  Difficulties Y es No Y es No
D izz in ess Y es No Y es No
L oss o f  strength Y es No Yes No
We are interested in your own current views of how you see your current insomnia.
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P lease  in d ic a te  how  m u ch  you ag re e  w ith  th e  fo llo w iig  s ta te m e n ts  a b o u t y o u r  in so m n ia  by 













IP1 My insomnia 
will last a 
short time
IP2 My insomnia 




IP3 My insomnia 
will last for a 
long time
IP4 My insomnia 
will pass 
quickly
IP5 I expect to 
have this 
insomnia fo r  
the rest o f  my 
life
IP6 My insomnia 
is a serious 
condition




IP8 My insomnia 
does not have 
much effect on 
my life
IP9 My insomnia 
strongly 
affects the way 
others see me




IP11 My insomnia 
causes
difficulties fo r  
those who are 
close to me
IP 12 There is a lot 









IP  14 The course o f  
my insomnia 
depends on me
IP  15 Nothing I do 
will affect my 
insomnia




IP  17 My actions 
will have no 
affect on the 
outcome o f  my 
insomnia
IP 18 My insomnia 
will improve in 
time
IP 19 There is very 
little that can 
be done to 
improve my 
insomnia





IP21 The negative 





IP22 My treatment 
can control my 
insomnia
IP23 There is 
nothing which 
can help my 
condition
IP24 The symptoms 
o f  my
condition are 
puzzling to me
IP25 My insomnia 






IP27 My insomnia 
doesn V make 
any sense to 
me
IP28 I have a clear 
picture or 
understanding 
o f  my 
condition
IP29 The symptoms 
o f  my 
insomnia 
change a great 
deal from day 
to day
IP30 My symptoms 
come and go 
in cycles
IP31 My insomnia 
is very
unpredictable






IP33 I get depressed 
when I think 
about my 
insomnia
IP34 When I think 
about my 
insomnia I get 
upset
IP35 My insomnia 
makes me feel 
angry'
IP36 My insomnia 
does not worry 
me
IP37 Having this 
insomnia 
makes me feel 
anxious
IP38 My insomnia 







G r e a t e r  G l a s g o w  
a n d  C ly d e
INSOMNIA COGNITION 
QUESTIONNAIRE
A g ree  D isag ree
1 2  3 4
1 B ecause o f  m y in so m n ia , 1 m iss th e  th in g s  I like to  do th e  m ost. 1 2 3 4
2 I can  h a n d le  th e  p ro b lem s re la te d  to  m y in so m n ia .
3 I have  le a rn e d  to  live w ith  m v in so m n ia .
4 D ealing  w ith  m y in so m n ia  has m ad e  m e a s tro n g e r  p e rso n .
5 M y in so m n ia  co n tro ls  m y life.
6 I have le a rn e d  a g re a t deal fro m  m y in so m n ia .
7 M y in so m n ia  m akes m e useless a t tim es.
8 M y in so m n ia  has m ad e  life m o re  p rec io u s  to me.
9 M y in so m n ia  p re v e n ts  m e fro m  d o ing  w h a t I w o u ld  re a lly  like  to  do.
10 I have le a rn e d  to accep t m y lim ita tio n  im p o sed  m y by in so m n ia .
11 L ook ing  b ack , I can  see th a t  m y in so m n ia  has also  b ro u g h t  a b o u t som e 
positive  ch an g es in m y life.
12 M y in so m n ia  lim its m e in ev e ry th in g  th a t  is im p o r ta n t  to  m e.
13 1 can  accep t m y in so m n ia  w ell.
14 I th in k  I can  h an d le  th e  p ro b lem s re la te d  to  m y in so m n ia , even  if  th e  
in so m n ia  gets w orse.
15 M y in so m n ia  fre q u e n tly  m akes m e feel help less
16 M y in so m n ia  has he lped  m e rea lise  w h a t’s im p o r ta n t  in  life
17 I can  cope effectively  w ith  m y in so m n ia .






G r e a t e r  G l a s g o w  
a n d  C ly d e
BRIEF COPE
INSTRUCTIONS: W e are interested in how people respond when they confront difficult or stressful events 
in their lives. There are lots o f  ways to try to deal with stress. This questionnaire asks you to indicate what 
you generally do and feel, when you  experience stressful events. Obviously, different events bring out 
somewhat different responses, but think about what you usually do when you are under a lot o f  stress.
Then respond to each o f  the following items by blackening one num ber on your answer sheet for each, using 
the response choices listed ju st below. Please try to respond to each item separately in your m ind from each 
other item. Choose your answ ers thoughtfully, and make your answers as true FOR YOU as you can. Please 
answer every item. There are no “right” or “wrong" answers, so choose the most accurate answer for YOU - 
not what you think “m ost people” would say or do. Indicate what YOU usually do when YOU experience a 
stressful event.
1 2  3 4
I usually don 't do I usually do this I usually do this I usually do this
this at all a little bit a medium am ount a lot
1. I 've  been concentrating my efforts on doing som ething about the situation 
I 'm  in.
1 2 3 4
2. I 've  been trying to com e up with a strategy about what to do. 1 2 3 4
3. I 'v e  been trying to see it in a different light, to make it seem more 
positive.
1 2 3 4
4. I 'v e  been accepting the reality o f the fact that it has happened. 1 2 3 4
5. I ’ve been making jokes about it. 1 2 3 4
6. I ’ve been trying to find com fort in my religion or spiritual beliefs. 1 2 3 4
7. I ’ve been getting em otional support from others. 1 2 3 4
8. I ’ve been trying to get advice or help from other people about what to do. 1 2 3 4
9. I 'v e  been turning to work or other activities to take my mind o ff things. 1 2 3 4
10. I 've  been saying to m yself “this isn 't real.” 1 2 3 4
11. I ’ve been saying things to let my unpleasant feelings escape. 1 2 3 4
12. I 'v e  been using alcohol or other drugs to make m yself feel better.. 1 2 3 4
13. I ’ve been giving up trying to deal with it. 1 2 3 4
14. I 've  been criticizing myself. 1 2 3 4
15. I ’ve been learning to live with it. 1 2 3 4
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16. I’ve been taking action to try to make the situation better. 1 2 3 4
17. I ’ve been thinking hard about what steps to take. 1 2 3 4
18. I ’ve been looking for something good in what is happening. 1 2 3 4
19. I ’ve been making fun o f the situation. 1 2 3 4
20. I ’ve been praying or meditating. 1 2 3 4
21. I ’ve been getting comfort and understanding from someone. 1 2 3 4
22. I ’ve been getting help and advice from other people. 1 2 3 4
23. I ’ve been doing something to think about it less, such as going to movies, 
watching TV, reading, 
daydreaming, sleeping, or shopping.
1 2 3 4
24. I ’ve been refusing to believe that it has happened. 2 3 4 4
25. I ’ve been expressing my negative feelings. 1 2 3 4
26. I ’ve been using alcohol or other drugs to help me get through it. 1 2 3 4
27. I ’ve been giving up the attempt to cope. 1 2 3 4







G r e a t e r  G l a s g o w  
a n d  C ly d e
Options that may be considered for sleep problems are described below. Please read the 
description o f  each option and answer each question as it would apply to your sleep problem. For 
each question, circle the number that you feel most appropriately represents your views. If you do 





1 usually have trouble falling asleep
2 3 4 5 6
Very much
Option 1: Behavioural treatment
This is a nondrug treatment method aimed at teaching individuals with a set o f  skills 
to help overcome their sleep problem. It provides specific guidelines for changing 
poor sleep habits and for regulating sleep schedules. Education about sleep hygiene 
factors (e.g. bedroom environment) is also provided.
1. How acceptable would you consider this method for your sleep problem?
1 2  3 4 5 6
Not at all acceptable Very acceptable
2. How acceptable would you consider this method for other people with 
sleep problems?
1 2 3 4 5 6
Not at all acceptable Very acceptable
3. How willing would you be to adhere to this method if recommended for your sleep 
problem?
1 2  3 4 5 6
Not at all willing Very willing
153
4. How suitable do you think this method would be for:
(A) difficulty falling asleep at bedtime?
1 2 3 4 5 6
Not at all suitable Very suitable
(B) Difficulty staying asleep during the night?
1 2 3 4 5 6
Not at all suitable Very suitable
5. How effective do you believe this treatment would be in the short term?
1 2 3 4 5 6
Not at all effective Very effective
6. How effective do you believe do you believe this method would be for producing a 
permanent cure?
1 2 3 4 5 6
Not at all effective Very effective
7. In addition to improving sleep, how effective would this method be for 
improving other aspects of your daytime functioning (e.g. alertness, 
performance, behaviour)?
1 2 3 4 5 6
Not at all effective Very effective
8. To what extent would this method produce side-effects?
1 2 3 4 5 6
Very strong No side
Side effects effect
154
Option 2: Pharmacological treatment
This drug treatment consists of taking a prescribed pill at a specified time. The 
prescribed medication is a naturally occurring hormone which is essential for sleep. 
The specific dosage would be based on the nature and severity of your sleep 
problem.
1. How acceptable would you consider this method for your sleep problem?
1 2 3 4 5 6
Not at all acceptable Very acceptable
2. How acceptable would you consider this method for other people with sleep problems?
1 2 3 4 5 6
Not at all acceptable Very acceptable
3. How willing would you be to adhere to this method if recommended for your sleep 
problem?
1 2 3 4 5 6
Not at all willing Very willing
4. How suitable do you think this method would be for:
a. difficulty falling asleep at bedtime?
1 2  3 4
Not at all suitable Very suitable
1 2 
Not at all suitable
b. Difficulty staying asleep during the night?
3 4 5
Very suitable
5. How effective do you believe this treatment would be in the short term?
1 2 
Not at all effective Very effective
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6. How effective do you believe do you believe this method would be for producing a 
permanent cure?
1 2 3 4 5 6
Not at all effective Very effective
7. In addition to improving sleep, how effective would this method be for improving 
other aspects of your daytime functioning (e.g. alertness, performance, behaviour)?
1 2 3 4 5 6
Not at all effective Very effective
8. To what extent would this method produce side-effects?
1 2 3 4 5 6
Very strong No side
Side effects effects
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Option 3: acceptance treatment
This is a nondrug treatment method aimed at encouraging acceptance of insomnia. 
It is designed to develop strategies for overcoming the impact that insomnia has on 
your life (e.g. engaging in increased activity, reducing distress caused by insomnia 
associated thinking).
1. How acceptable would you consider this method for your sleep problem?
1 2 
Not at all acceptable
6
Very acceptable
2. How acceptable would you consider this method for other people with sleep problems?
1 2 
Not at all acceptable Very acceptable
3. How willing would you be to adhere to this method if recommended for your sleep 
problem?
1 2 
Not at all willing
4
Very willing
4. How suitable do you think this method would be for:
a. difficulty falling asleep at bedtime?
1 2 
Not at all suitable Very suitable
1 2 
Not at all suitable
b. Difficulty staying asleep during the night?
3 4
Very suitable
5. How effective do you believe this treatment would be in the short term?
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1 2 
Not at all effective
3 4 5 6
Very effective
6. How effective do you believe do you believe this method would be for producing a 
permanent cure?
1 2 3 4 5 6
Not at all effective Very effective
7. In addition to improving sleep, how effective would this method be for improving 
other aspects of your daytime functioning (e.g. alertness, performance, behaviour)?
1 2 3 4 5 6
Not at all effective Very effective
8. To what extent would this method produce side-effects?
1 2 3 4 5 6








Group 0 Normal 31sleeper
1 PI 31
2 II 30
Tests of Between-Subjects Effects
Dependent Variable: SF-36 v.2 physical scale
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 3320.2353 3 1106.745 7.096 .000
Intercept 27423.531 1 27423.531 175.832 .000
ageSQRT 595.867 1 595.867 3.821 .054
Group 1925.610 2 962.805 6.173 .003
Error 13724.854 88 155.964
Total 649449.820 92
Corrected Total 17045.090 91
a- R Squared = .195 (Adjusted R Squared = .167)
Tests of Between-Subjects Effects
Dependent Variable: SF-36 v.2 mental scale
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 6421.8333 3 2140.611 9.093 .000
Intercept 7515.399 1 7515.399 31.925 .000
ageSQRT 1119.417 1 1119.417 4.755 .032
Group 6222.493 2 3111.246 13.216 .000
Error 20716.151 88 235.411
Total 479026.557 92
Corrected Total 27137.984 91
a- R Squared = .237 (Adjusted R Squared = .211)
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Tests of Between-Subjects Effects
Dependent Variable: BriefCope Planning
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 5.776a 3 1.925 .666 .575
Intercept 54.337 1 54.337 18.804 .000
ageSQRT 2.658 1 2.658 .920 .340
Group 4.276 2 2.138 .740 .480
Error 231.176 80 2.890
Total 2800.000 84
Corrected Total 236.952 83
a- R Squared = .024 (Adjusted R Squared = -.012)
Tests of Between-Subjects Effects
Dependent Variable: BriefCope_Positive Reframing
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 11.116a 3 3.705 1.199 .316
Intercept 49.773 1 49.773 16.101 .000
ageSQRT 1.534 1 1.534 .496 .483
Group 10.741 2 5.371 1.737 .183
Error 247.301 80 3.091
Total 2429.000 84
Corrected Total 258.417 83
a- R Squared = .043 (Adjusted R Squared = .007)
Tests of Between-Subjects Effects
Dependent Variable: BriefCope_Positive Reframing
Source
Type III Sum 
of Squares df Mean Square F Sig.
Corrected Model 11.116a 3 3.705 1.199 .316
Intercept 49.773 1 49.773 16.101 .000
ageSQRT 1.534 1 1.534 .496 .483
Group 10.741 2 5.371 1.737 .183
Error 247.301 80 3.091
Total 2429.000 84
Corrected Total 258.417 83
a- R Squared = .043 (Adjusted R Squared = .007)
160
Appendix 2.10
Scale Descriptives for Major Research Project.




IPQ-R /  Timeline acute/chronic 6 0.81(57) 0 .7 4 -0 .8 4
IPQ-R /  Timeline cyclical 4 0.89 (56) 0 .8 2 -0 .8 9
IPQ-R / Personal control 6 0.76 (57) 0 .6 3 -0 .7 3
IPQ-R / Treatment control (minus IPQ-R-19) 4 0.68 (55) 0 .5 7 -0 .8 4
ICQ / Helplessness Subscale 5 0.77 (54) 0 .7 2 -0 .7 8
ICQ / Acceptance Subscale 6 0.81 (57) 0 .7 4 -0 .8 2
TAS / Acceptance subscale 8 0.92 (58) 0 .9 0 -0 .9 3
TAS / Behavioural subscale 8 0.88 (58) 0 .8 4 -0 .8 8
TAS / Pharmacological subscale 8 0.82 (58) 0 .7 7 -0 .8 4
SF36 / Physical Health Scale 4 0.75 (92) 0 .6 6 -0 .7 3
SF36 / Mental Health Scale 4 0.82 (92) 0.76 -0 .80
“Numbers vary as individual scales are missing for some participants.
Abbreviations:
IPQ-R, Illness Perception Questionnaire -  Revised; ICQ, Illness Cognition Questionnaire; TAS, Treatment Acceptability Scale.
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